RU2431635C2 - Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 - Google Patents
Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 Download PDFInfo
- Publication number
- RU2431635C2 RU2431635C2 RU2007119449/04A RU2007119449A RU2431635C2 RU 2431635 C2 RU2431635 C2 RU 2431635C2 RU 2007119449/04 A RU2007119449/04 A RU 2007119449/04A RU 2007119449 A RU2007119449 A RU 2007119449A RU 2431635 C2 RU2431635 C2 RU 2431635C2
- Authority
- RU
- Russia
- Prior art keywords
- phenyl
- chlorophenyl
- group
- pyrimidin
- dihydropyrazolo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 39
- 102100033868 Cannabinoid receptor 1 Human genes 0.000 title claims abstract 6
- 101710187010 Cannabinoid receptor 1 Proteins 0.000 title claims abstract 6
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 9
- 201000010099 disease Diseases 0.000 claims abstract 7
- 238000000034 method Methods 0.000 claims abstract 6
- 208000035475 disorder Diseases 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- -1 methylsulphonylaminomethyl Chemical group 0.000 claims 196
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 97
- 229910052736 halogen Inorganic materials 0.000 claims 70
- 150000002367 halogens Chemical class 0.000 claims 70
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 61
- 150000003254 radicals Chemical class 0.000 claims 56
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 51
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 50
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 49
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 38
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 37
- 125000004093 cyano group Chemical group *C#N 0.000 claims 36
- 125000000753 cycloalkyl group Chemical group 0.000 claims 36
- 125000001072 heteroaryl group Chemical group 0.000 claims 33
- 229910052739 hydrogen Inorganic materials 0.000 claims 30
- 239000001257 hydrogen Substances 0.000 claims 30
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 claims 28
- 125000004076 pyridyl group Chemical group 0.000 claims 19
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 18
- 229910052757 nitrogen Inorganic materials 0.000 claims 18
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 17
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 17
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 16
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 14
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 13
- 150000002431 hydrogen Chemical class 0.000 claims 13
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 13
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 12
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 12
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 12
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 12
- 229910052794 bromium Inorganic materials 0.000 claims 12
- 229910052801 chlorine Inorganic materials 0.000 claims 12
- 239000000460 chlorine Substances 0.000 claims 12
- 229910052731 fluorine Inorganic materials 0.000 claims 12
- 239000011737 fluorine Substances 0.000 claims 12
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 11
- 125000002541 furyl group Chemical group 0.000 claims 11
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 11
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 claims 11
- 125000004193 piperazinyl group Chemical group 0.000 claims 11
- 125000003226 pyrazolyl group Chemical group 0.000 claims 11
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 11
- 125000004429 atom Chemical group 0.000 claims 10
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 10
- 125000002950 monocyclic group Chemical group 0.000 claims 10
- 125000006413 ring segment Chemical group 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 9
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 9
- 208000008589 Obesity Diseases 0.000 claims 9
- 125000005997 bromomethyl group Chemical group 0.000 claims 9
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 9
- 235000020824 obesity Nutrition 0.000 claims 9
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 8
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
- 235000014632 disordered eating Nutrition 0.000 claims 7
- 125000004494 ethyl ester group Chemical group 0.000 claims 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 7
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 6
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 6
- 230000001404 mediated effect Effects 0.000 claims 6
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 6
- 125000003386 piperidinyl group Chemical group 0.000 claims 6
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 6
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 6
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 claims 6
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 5
- 150000001204 N-oxides Chemical class 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000002619 bicyclic group Chemical group 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 5
- 150000004677 hydrates Chemical class 0.000 claims 5
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 claims 5
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 229920006395 saturated elastomer Polymers 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- 125000004434 sulfur atom Chemical group 0.000 claims 5
- CPEONABTMRSIKA-UHFFFAOYSA-N 1,4$l^{2}-oxazinane Chemical compound C1COCC[N]1 CPEONABTMRSIKA-UHFFFAOYSA-N 0.000 claims 4
- CSOYDALHEQEMAK-UHFFFAOYSA-N 2h-pyrimidine-1-carboxylic acid Chemical compound OC(=O)N1CN=CC=C1 CSOYDALHEQEMAK-UHFFFAOYSA-N 0.000 claims 4
- 208000030814 Eating disease Diseases 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 4
- 230000037406 food intake Effects 0.000 claims 4
- 235000012631 food intake Nutrition 0.000 claims 4
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 claims 4
- RHFWLPWDOYJEAL-UHFFFAOYSA-N 1,2-oxazol-3-amine Chemical compound NC=1C=CON=1 RHFWLPWDOYJEAL-UHFFFAOYSA-N 0.000 claims 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 3
- 239000005711 Benzoic acid Substances 0.000 claims 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 3
- 206010006550 Bulimia nervosa Diseases 0.000 claims 3
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 claims 3
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 claims 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 3
- 208000010235 Food Addiction Diseases 0.000 claims 3
- 206010020772 Hypertension Diseases 0.000 claims 3
- 150000001408 amides Chemical class 0.000 claims 3
- 235000010233 benzoic acid Nutrition 0.000 claims 3
- 125000006226 butoxyethyl group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims 3
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 claims 3
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 claims 3
- 125000001153 fluoro group Chemical group F* 0.000 claims 3
- 125000002883 imidazolyl group Chemical group 0.000 claims 3
- 230000001771 impaired effect Effects 0.000 claims 3
- 229910052740 iodine Inorganic materials 0.000 claims 3
- 239000011630 iodine Chemical group 0.000 claims 3
- 125000000842 isoxazolyl group Chemical group 0.000 claims 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 3
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims 3
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims 3
- 125000002971 oxazolyl group Chemical group 0.000 claims 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims 3
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims 3
- 125000002098 pyridazinyl group Chemical group 0.000 claims 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 3
- 125000001544 thienyl group Chemical group 0.000 claims 3
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 3
- COEHPBLCHQVRQQ-UHFFFAOYSA-N 1-(4-aminophenyl)-5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(N)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 COEHPBLCHQVRQQ-UHFFFAOYSA-N 0.000 claims 2
- YVXXWCRYMRJYPD-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-9-phenylpurin-6-one Chemical compound ClC1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 YVXXWCRYMRJYPD-UHFFFAOYSA-N 0.000 claims 2
- KWADLQINXZGEPT-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2-fluorophenyl)-9-phenylpurin-6-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 KWADLQINXZGEPT-UHFFFAOYSA-N 0.000 claims 2
- KBJBFEJPSUUKIE-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-methoxyphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(OC)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 KBJBFEJPSUUKIE-UHFFFAOYSA-N 0.000 claims 2
- CNLORCDLZNDEQX-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(methoxymethyl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(COC)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 CNLORCDLZNDEQX-UHFFFAOYSA-N 0.000 claims 2
- BNFMAWGNJLMYEG-UHFFFAOYSA-N 4-[1-(4-chlorophenyl)-6-oxo-9-phenylpurin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 BNFMAWGNJLMYEG-UHFFFAOYSA-N 0.000 claims 2
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 2
- MJHKIDXPBNVAGM-UHFFFAOYSA-N 5,6-bis(3-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 MJHKIDXPBNVAGM-UHFFFAOYSA-N 0.000 claims 2
- JQDKZDULLRGNAR-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-(2-nitrophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound [O-][N+](=O)C1=CC=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 JQDKZDULLRGNAR-UHFFFAOYSA-N 0.000 claims 2
- LLWGEJHKYINBQU-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 LLWGEJHKYINBQU-UHFFFAOYSA-N 0.000 claims 2
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 2
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 229930003827 cannabinoid Natural products 0.000 claims 2
- 239000003557 cannabinoid Substances 0.000 claims 2
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 claims 2
- 206010027175 memory impairment Diseases 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 150000004702 methyl esters Chemical class 0.000 claims 2
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims 2
- 208000030212 nutrition disease Diseases 0.000 claims 2
- 208000019180 nutritional disease Diseases 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 claims 2
- WTVSOESDARPVQO-UHFFFAOYSA-N triazolo[4,5-d]pyrimidin-7-one Chemical compound O=C1N=CN=C2N=NN=C12 WTVSOESDARPVQO-UHFFFAOYSA-N 0.000 claims 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 claims 1
- CPHOHOZBKYXBOE-UHFFFAOYSA-N 1,5,6-triphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C=1C=CC=CC=1C1=NC=2N(C=3C=CC=CC=3)N=CC=2C(=O)N1C1=CC=CC=C1 CPHOHOZBKYXBOE-UHFFFAOYSA-N 0.000 claims 1
- RTRZUHVDRDFUOY-UHFFFAOYSA-N 1-(4-aminophenyl)-5,6-bis(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(N)=CC=C1N1C(N=C(C=2C=CC(Cl)=CC=2)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 RTRZUHVDRDFUOY-UHFFFAOYSA-N 0.000 claims 1
- BIQCBYACCKCCMG-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,3-difluorophenyl)-9-phenylpurin-6-one Chemical compound FC1=CC=CC(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1F BIQCBYACCKCCMG-UHFFFAOYSA-N 0.000 claims 1
- NPRZWKHHDOMTDO-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-7-phenylpurin-6-one Chemical compound ClC1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N(C=1C=CC=CC=1)C=N2 NPRZWKHHDOMTDO-UHFFFAOYSA-N 0.000 claims 1
- SISTXBOAUQTZBZ-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-8-ethyl-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl SISTXBOAUQTZBZ-UHFFFAOYSA-N 0.000 claims 1
- WCFMNYYLLCKQLD-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-8-methyl-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(C)=NC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl WCFMNYYLLCKQLD-UHFFFAOYSA-N 0.000 claims 1
- UAINFDTULNWQRV-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-9-(2-methoxy-5-methylphenyl)purin-6-one Chemical compound COC1=CC=C(C)C=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Br)=CC=2)C2=O)=C2N=C1 UAINFDTULNWQRV-UHFFFAOYSA-N 0.000 claims 1
- CVVLYVOVDYSUHM-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-9-(4-methylphenyl)purin-6-one Chemical compound C1=CC(C)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Br)=CC=2)C2=O)=C2N=C1 CVVLYVOVDYSUHM-UHFFFAOYSA-N 0.000 claims 1
- KCHBEOPRACSEGD-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-9-[3-(trifluoromethoxy)phenyl]purin-6-one Chemical compound FC(F)(F)OC1=CC=CC(N2C3=C(C(N(C=4C=CC(Br)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 KCHBEOPRACSEGD-UHFFFAOYSA-N 0.000 claims 1
- WTXIVQKGPUYREK-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(2-methylphenyl)-9-phenylpurin-6-one Chemical compound CC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 WTXIVQKGPUYREK-UHFFFAOYSA-N 0.000 claims 1
- ACKPWJUMPHEZIQ-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(3,4-dichlorophenyl)-9-phenylpurin-6-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 ACKPWJUMPHEZIQ-UHFFFAOYSA-N 0.000 claims 1
- YSWZCFCTKUTUAD-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(3-fluorophenyl)-9-phenylpurin-6-one Chemical compound FC1=CC=CC(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1 YSWZCFCTKUTUAD-UHFFFAOYSA-N 0.000 claims 1
- CAOAVRGXYIFZCM-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(3-methylphenyl)-9-phenylpurin-6-one Chemical compound CC1=CC=CC(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1 CAOAVRGXYIFZCM-UHFFFAOYSA-N 0.000 claims 1
- NSFGXVRAAXFIHT-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-chlorophenyl)-7-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N(C=1C=CC=CC=1)C=N2 NSFGXVRAAXFIHT-UHFFFAOYSA-N 0.000 claims 1
- FCUNMFYODCOLGK-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-chlorophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 FCUNMFYODCOLGK-UHFFFAOYSA-N 0.000 claims 1
- JEXJTVGJOUGEIK-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-ethylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(CC)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 JEXJTVGJOUGEIK-UHFFFAOYSA-N 0.000 claims 1
- HKRQWMFEHPCYOR-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-fluoro-3-methylphenyl)-9-phenylpurin-6-one Chemical compound C1=C(F)C(C)=CC(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1 HKRQWMFEHPCYOR-UHFFFAOYSA-N 0.000 claims 1
- OQRSWWCIZIRDKL-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-methylphenyl)-6-oxo-9-phenylpurine-8-carbonitrile Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=C(C#N)N2C1=CC=CC=C1 OQRSWWCIZIRDKL-UHFFFAOYSA-N 0.000 claims 1
- ABWSEZBDTUKXIQ-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-methylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 ABWSEZBDTUKXIQ-UHFFFAOYSA-N 0.000 claims 1
- GNMJDBASQVVLQA-UHFFFAOYSA-N 1-(4-bromophenyl)-2-(4-tert-butylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(C(C)(C)C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 GNMJDBASQVVLQA-UHFFFAOYSA-N 0.000 claims 1
- JISQYBYCOOTQNI-UHFFFAOYSA-N 1-(4-bromophenyl)-2-[3-fluoro-4-(trifluoromethyl)phenyl]-9-phenylpurin-6-one Chemical compound C1=C(C(F)(F)F)C(F)=CC(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1 JISQYBYCOOTQNI-UHFFFAOYSA-N 0.000 claims 1
- HKRFOIAWIDPALW-UHFFFAOYSA-N 1-(4-bromophenyl)-8-ethyl-2-(4-ethylphenyl)-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=C(CC)C=C1 HKRFOIAWIDPALW-UHFFFAOYSA-N 0.000 claims 1
- IBHGHBZOPWSKNB-UHFFFAOYSA-N 1-(4-bromophenyl)-8-ethyl-2-(4-methylphenyl)-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=C(C)C=C1 IBHGHBZOPWSKNB-UHFFFAOYSA-N 0.000 claims 1
- NZEXJDPYNLVJIL-UHFFFAOYSA-N 1-(4-bromophenyl)-8-ethyl-9-phenyl-2-(4-propylphenyl)purin-6-one Chemical compound C1=CC(CCC)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=C(CC)N2C1=CC=CC=C1 NZEXJDPYNLVJIL-UHFFFAOYSA-N 0.000 claims 1
- QWMMPQKBYGZDSP-UHFFFAOYSA-N 1-(4-bromophenyl)-8-ethyl-9-phenyl-2-[4-(trichloromethyl)phenyl]purin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=C(C(Cl)(Cl)Cl)C=C1 QWMMPQKBYGZDSP-UHFFFAOYSA-N 0.000 claims 1
- YJVARSALAHOUNO-UHFFFAOYSA-N 1-(4-bromophenyl)-8-ethyl-9-phenyl-2-[4-(trifluoromethyl)phenyl]purin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=C(C(F)(F)F)C=C1 YJVARSALAHOUNO-UHFFFAOYSA-N 0.000 claims 1
- LJXWDYAQBPVZNB-UHFFFAOYSA-N 1-(4-bromophenyl)-8-methoxy-2-(4-methylphenyl)-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(OC)=NC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=C(C)C=C1 LJXWDYAQBPVZNB-UHFFFAOYSA-N 0.000 claims 1
- BBCKSRAVRYUKEE-UHFFFAOYSA-N 1-(4-bromophenyl)-9-(2-methoxy-5-methylphenyl)-2-(4-methylphenyl)purin-6-one Chemical compound COC1=CC=C(C)C=C1N1C(N=C(C=2C=CC(C)=CC=2)N(C=2C=CC(Br)=CC=2)C2=O)=C2N=C1 BBCKSRAVRYUKEE-UHFFFAOYSA-N 0.000 claims 1
- CPXWFXCOPYTEFW-UHFFFAOYSA-N 1-(4-bromophenyl)-9-cyclopropyl-2-(2,4-dichlorophenyl)purin-6-one Chemical compound ClC1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1CC1 CPXWFXCOPYTEFW-UHFFFAOYSA-N 0.000 claims 1
- YUBCVFAKLSQLCT-UHFFFAOYSA-N 1-(4-bromophenyl)-9-phenyl-2-(4-propylphenyl)purin-6-one Chemical compound C1=CC(CCC)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 YUBCVFAKLSQLCT-UHFFFAOYSA-N 0.000 claims 1
- JWQLSSQYJCSNQE-UHFFFAOYSA-N 1-(4-bromophenyl)-9-phenyl-2-[2-(trifluoromethyl)phenyl]purin-6-one Chemical compound FC(F)(F)C1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 JWQLSSQYJCSNQE-UHFFFAOYSA-N 0.000 claims 1
- OWHPKWMVOHOJQK-UHFFFAOYSA-N 1-(4-bromophenyl)-9-phenyl-2-[4-(trifluoromethyl)phenyl]purin-6-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 OWHPKWMVOHOJQK-UHFFFAOYSA-N 0.000 claims 1
- MGBNEBUYKGTHDB-UHFFFAOYSA-N 1-(4-chlorophenyl)-2,9-diphenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1 MGBNEBUYKGTHDB-UHFFFAOYSA-N 0.000 claims 1
- FIQWJZOGTDEVLE-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(2,5-dichlorophenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(C=2C(=CC=C(Cl)C=2)Cl)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl FIQWJZOGTDEVLE-UHFFFAOYSA-N 0.000 claims 1
- TXMVQEQFCAFDLZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(2,5-difluorophenyl)purin-6-one Chemical compound FC1=CC=C(F)C(N2C=3C(=O)N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=NC=3N=C2)=C1 TXMVQEQFCAFDLZ-UHFFFAOYSA-N 0.000 claims 1
- QCRFKWHUKVILSF-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(2,5-dimethylphenyl)purin-6-one Chemical compound CC1=CC=C(C)C(N2C=3C(=O)N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=NC=3N=C2)=C1 QCRFKWHUKVILSF-UHFFFAOYSA-N 0.000 claims 1
- RCVZUUYMEDUFOH-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(2-fluorophenyl)purin-6-one Chemical compound FC1=CC=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 RCVZUUYMEDUFOH-UHFFFAOYSA-N 0.000 claims 1
- OBILLLXSLILQHP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(2-nitrophenyl)purin-6-one Chemical compound [O-][N+](=O)C1=CC=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 OBILLLXSLILQHP-UHFFFAOYSA-N 0.000 claims 1
- CMIPEXNCULLMCF-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(3,5-difluorophenyl)purin-6-one Chemical compound FC1=CC(F)=CC(N2C=3C(=O)N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=NC=3N=C2)=C1 CMIPEXNCULLMCF-UHFFFAOYSA-N 0.000 claims 1
- MBLYGJWSJKSGAL-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(3,5-dimethylphenyl)purin-6-one Chemical compound CC1=CC(C)=CC(N2C=3C(=O)N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=NC=3N=C2)=C1 MBLYGJWSJKSGAL-UHFFFAOYSA-N 0.000 claims 1
- QASQELUXWXAFFP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(3-methoxyphenyl)purin-6-one Chemical compound COC1=CC=CC(N2C=3C(=O)N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=NC=3N=C2)=C1 QASQELUXWXAFFP-UHFFFAOYSA-N 0.000 claims 1
- TXHXFKSFTZTSJZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(4-fluoro-2-methylphenyl)purin-6-one Chemical compound CC1=CC(F)=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 TXHXFKSFTZTSJZ-UHFFFAOYSA-N 0.000 claims 1
- WCSKIPQMRUTEAD-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(4-methylsulfonylphenyl)purin-6-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 WCSKIPQMRUTEAD-UHFFFAOYSA-N 0.000 claims 1
- OCGMQWBVWPCTJK-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(5-fluoro-2-methoxyphenyl)purin-6-one Chemical compound COC1=CC=C(F)C=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 OCGMQWBVWPCTJK-UHFFFAOYSA-N 0.000 claims 1
- LTEWKUGVBBHESZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(furan-3-yl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(C2=COC=C2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl LTEWKUGVBBHESZ-UHFFFAOYSA-N 0.000 claims 1
- QTPKFYYYYRIUJY-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-[2-(trifluoromethyl)phenyl]purin-6-one Chemical compound FC(F)(F)C1=CC=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 QTPKFYYYYRIUJY-UHFFFAOYSA-N 0.000 claims 1
- KLOLNVAVGMVNCD-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-[3-(trifluoromethoxy)phenyl]purin-6-one Chemical compound FC(F)(F)OC1=CC=CC(N2C=3C(=O)N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=NC=3N=C2)=C1 KLOLNVAVGMVNCD-UHFFFAOYSA-N 0.000 claims 1
- XQBHKPPUSOSFPR-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-[4-(dimethylamino)phenyl]purin-6-one Chemical compound C1=CC(N(C)C)=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 XQBHKPPUSOSFPR-UHFFFAOYSA-N 0.000 claims 1
- TYWWCSROXVLYSN-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-[4-(hydroxymethyl)phenyl]purin-6-one Chemical compound C1=CC(CO)=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 TYWWCSROXVLYSN-UHFFFAOYSA-N 0.000 claims 1
- RZWLELXAKPGSLI-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-[4-(methylamino)phenyl]purin-6-one Chemical compound C1=CC(NC)=CC=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 RZWLELXAKPGSLI-UHFFFAOYSA-N 0.000 claims 1
- FHRKSTYRBJXXPU-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-pyridin-3-ylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(C=2C=NC=CC=2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl FHRKSTYRBJXXPU-UHFFFAOYSA-N 0.000 claims 1
- XKZDNZCXYAPPHU-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-pyridin-4-ylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(C=2C=CN=CC=2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl XKZDNZCXYAPPHU-UHFFFAOYSA-N 0.000 claims 1
- CSPUWZFSBPGYSP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-(2-methylhydrazinyl)-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(NNC)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl CSPUWZFSBPGYSP-UHFFFAOYSA-N 0.000 claims 1
- HYHGJRZGBFRGHH-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-[2-(dimethylamino)ethoxy]-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(OCCN(C)C)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl HYHGJRZGBFRGHH-UHFFFAOYSA-N 0.000 claims 1
- DJGLZQYVMGARLP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-[2-hydroxyethyl(methyl)amino]-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(N(CCO)C)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl DJGLZQYVMGARLP-UHFFFAOYSA-N 0.000 claims 1
- UYMGJYPQHOWSHP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-[ethyl(methyl)amino]-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(N(C)CC)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl UYMGJYPQHOWSHP-UHFFFAOYSA-N 0.000 claims 1
- GBCPKTYMSJDBLZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-ethyl-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl GBCPKTYMSJDBLZ-UHFFFAOYSA-N 0.000 claims 1
- ATFVDGLQGPVEAL-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-methoxy-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(OC)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl ATFVDGLQGPVEAL-UHFFFAOYSA-N 0.000 claims 1
- IDSWGZUBZCEAPC-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-methyl-9-phenylpurin-6-one Chemical compound C=1C=CC=CC=1N1C(C)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(Cl)C=C1Cl IDSWGZUBZCEAPC-UHFFFAOYSA-N 0.000 claims 1
- XROJIIANSPENBT-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-8-morpholin-4-yl-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=C(N2C=3C=CC=CC=3)N3CCOCC3)=C2N=C1C1=CC=C(Cl)C=C1Cl XROJIIANSPENBT-UHFFFAOYSA-N 0.000 claims 1
- DTUPXWNDGULTNC-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(2,5-dichlorophenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C(=CC=C(Cl)C=3)Cl)=C2N=C1C1=CC=C(Cl)C=C1Cl DTUPXWNDGULTNC-UHFFFAOYSA-N 0.000 claims 1
- FVYLGUOQWRTRAY-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(2,5-difluorophenyl)purin-6-one Chemical compound FC1=CC=C(F)C(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 FVYLGUOQWRTRAY-UHFFFAOYSA-N 0.000 claims 1
- AJUSYBLJDRQPCW-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(2,5-dimethylphenyl)purin-6-one Chemical compound CC1=CC=C(C)C(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 AJUSYBLJDRQPCW-UHFFFAOYSA-N 0.000 claims 1
- VNSXWQBHNDUGKE-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(2-fluorophenyl)purin-6-one Chemical compound FC1=CC=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 VNSXWQBHNDUGKE-UHFFFAOYSA-N 0.000 claims 1
- QUJRWORNCBNZFK-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(2-methoxy-5-methylphenyl)purin-6-one Chemical compound COC1=CC=C(C)C=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 QUJRWORNCBNZFK-UHFFFAOYSA-N 0.000 claims 1
- HQGGHGIXPNOYEL-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(2-nitrophenyl)purin-6-one Chemical compound [O-][N+](=O)C1=CC=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 HQGGHGIXPNOYEL-UHFFFAOYSA-N 0.000 claims 1
- SIAIJXCFOIQWTP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(2-propan-2-yloxyphenyl)purin-6-one Chemical compound CC(C)OC1=CC=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 SIAIJXCFOIQWTP-UHFFFAOYSA-N 0.000 claims 1
- VMNRGAKVZHANIN-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(3,5-difluorophenyl)purin-6-one Chemical compound FC1=CC(F)=CC(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 VMNRGAKVZHANIN-UHFFFAOYSA-N 0.000 claims 1
- FNZXFTARNYOGEP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(3,5-dimethylphenyl)purin-6-one Chemical compound CC1=CC(C)=CC(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 FNZXFTARNYOGEP-UHFFFAOYSA-N 0.000 claims 1
- RVVFCGJZDMCCQA-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(3-methoxyphenyl)purin-6-one Chemical compound COC1=CC=CC(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 RVVFCGJZDMCCQA-UHFFFAOYSA-N 0.000 claims 1
- KACXTCQDYMMULF-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(3-nitrophenyl)purin-6-one Chemical compound [O-][N+](=O)C1=CC=CC(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 KACXTCQDYMMULF-UHFFFAOYSA-N 0.000 claims 1
- SMKCAMAVBTUHEW-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(4-methylsulfonylphenyl)purin-6-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 SMKCAMAVBTUHEW-UHFFFAOYSA-N 0.000 claims 1
- BEEVPQOHJGCMOT-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(5-fluoro-2-methylphenyl)purin-6-one Chemical compound CC1=CC=C(F)C=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 BEEVPQOHJGCMOT-UHFFFAOYSA-N 0.000 claims 1
- LPQYCEHYVPLVDJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-(furan-3-yl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C3=COC=C3)=C2N=C1C1=CC=C(Cl)C=C1Cl LPQYCEHYVPLVDJ-UHFFFAOYSA-N 0.000 claims 1
- VTEPRCAJKKHLOB-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-[2-(trifluoromethyl)phenyl]purin-6-one Chemical compound FC(F)(F)C1=CC=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 VTEPRCAJKKHLOB-UHFFFAOYSA-N 0.000 claims 1
- LIDQGYMZCPKUCZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-[3-(trifluoromethoxy)phenyl]purin-6-one Chemical compound FC(F)(F)OC1=CC=CC(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)N=C2)=C1 LIDQGYMZCPKUCZ-UHFFFAOYSA-N 0.000 claims 1
- IXIJOBVAHLLALE-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-[4-(dimethylamino)phenyl]purin-6-one Chemical compound C1=CC(N(C)C)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 IXIJOBVAHLLALE-UHFFFAOYSA-N 0.000 claims 1
- IFTNONPESMRNQF-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-[4-(hydroxymethyl)phenyl]purin-6-one Chemical compound C1=CC(CO)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 IFTNONPESMRNQF-UHFFFAOYSA-N 0.000 claims 1
- VSSALXJFVMMRQW-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1Cl VSSALXJFVMMRQW-UHFFFAOYSA-N 0.000 claims 1
- JJIURWRFWSNXCB-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-pyridin-3-ylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=NC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1Cl JJIURWRFWSNXCB-UHFFFAOYSA-N 0.000 claims 1
- JDVKBXIHSOCMAV-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2,4-dimethylphenyl)-9-phenylpurin-6-one Chemical compound CC1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 JDVKBXIHSOCMAV-UHFFFAOYSA-N 0.000 claims 1
- PHLPZNWPHCEADL-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(2-fluoro-4-methylphenyl)-9-phenylpurin-6-one Chemical compound FC1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 PHLPZNWPHCEADL-UHFFFAOYSA-N 0.000 claims 1
- CZPBEGJZHWUKPZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-cyclohexylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2CCCCC2)C=C1 CZPBEGJZHWUKPZ-UHFFFAOYSA-N 0.000 claims 1
- VGMGRGYTOHHSAI-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-cyclopropylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2CC2)C=C1 VGMGRGYTOHHSAI-UHFFFAOYSA-N 0.000 claims 1
- NPJFTKJUWYOJER-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-ethenylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=C)C=C1 NPJFTKJUWYOJER-UHFFFAOYSA-N 0.000 claims 1
- IKMJZMDXNBXBAO-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-hydroxyphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(O)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 IKMJZMDXNBXBAO-UHFFFAOYSA-N 0.000 claims 1
- JYULPHKSRLTQDM-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-imidazol-1-ylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2C=NC=C2)C=C1 JYULPHKSRLTQDM-UHFFFAOYSA-N 0.000 claims 1
- HTKYPUUZJHYLPU-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-iodophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(I)C=C1 HTKYPUUZJHYLPU-UHFFFAOYSA-N 0.000 claims 1
- XBWMKZXADPXGMG-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-methoxyphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(OC)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 XBWMKZXADPXGMG-UHFFFAOYSA-N 0.000 claims 1
- AQTASVMWPMYTAR-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-methylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 AQTASVMWPMYTAR-UHFFFAOYSA-N 0.000 claims 1
- KXMHLCFEFPTJCX-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 KXMHLCFEFPTJCX-UHFFFAOYSA-N 0.000 claims 1
- SAZHJRVAMSDQJN-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(4-phenylphenyl)-9-[3-(trifluoromethoxy)phenyl]purin-6-one Chemical compound FC(F)(F)OC1=CC=CC(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C=CC(=CC=4)C=4C=CC=CC=4)=N3)=O)N=C2)=C1 SAZHJRVAMSDQJN-UHFFFAOYSA-N 0.000 claims 1
- CMDYERVPPMQQJM-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[2-fluoro-4-(trifluoromethyl)phenyl]-9-phenylpurin-6-one Chemical compound FC1=CC(C(F)(F)F)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 CMDYERVPPMQQJM-UHFFFAOYSA-N 0.000 claims 1
- ISHIJJKJSXCPPW-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(1,3-oxazol-5-yl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2OC=NC=2)C=C1 ISHIJJKJSXCPPW-UHFFFAOYSA-N 0.000 claims 1
- WNHYLOHEKJMOGU-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(2-chloropyrimidin-4-yl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2N=C(Cl)N=CC=2)C=C1 WNHYLOHEKJMOGU-UHFFFAOYSA-N 0.000 claims 1
- BOXDPJIUMJCZMT-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(2-fluorophenyl)phenyl]-9-phenylpurin-6-one Chemical compound FC1=CC=CC=C1C1=CC=C(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 BOXDPJIUMJCZMT-UHFFFAOYSA-N 0.000 claims 1
- SJIRSUMVHGVTSH-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(CC(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 SJIRSUMVHGVTSH-UHFFFAOYSA-N 0.000 claims 1
- FCTWOIBOJXJVGI-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(2-oxopiperidin-1-yl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2C(CCCC2)=O)C=C1 FCTWOIBOJXJVGI-UHFFFAOYSA-N 0.000 claims 1
- FDDVTIXOEMNXNA-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(2-oxopyrrolidin-1-yl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2C(CCC2)=O)C=C1 FDDVTIXOEMNXNA-UHFFFAOYSA-N 0.000 claims 1
- QQAXHJYXNWWARX-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(3,5-difluorophenyl)phenyl]-9-phenylpurin-6-one Chemical compound FC1=CC(F)=CC(C=2C=CC(=CC=2)C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 QQAXHJYXNWWARX-UHFFFAOYSA-N 0.000 claims 1
- MROOWUVAXBDEBA-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(3-fluorophenyl)phenyl]-9-phenylpurin-6-one Chemical compound FC1=CC=CC(C=2C=CC(=CC=2)C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 MROOWUVAXBDEBA-UHFFFAOYSA-N 0.000 claims 1
- LSWYXPOSEUPUNV-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(4-fluorophenyl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(F)=CC=C1C1=CC=C(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 LSWYXPOSEUPUNV-UHFFFAOYSA-N 0.000 claims 1
- RBUXSPCPIIMKJJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(6-oxo-1h-pyridin-3-yl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2=CNC(=O)C=C2)C=C1 RBUXSPCPIIMKJJ-UHFFFAOYSA-N 0.000 claims 1
- QYAXBQQYTZEMRY-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(diethylaminomethyl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(CN(CC)CC)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 QYAXBQQYTZEMRY-UHFFFAOYSA-N 0.000 claims 1
- SSXVUQNBYOWXNP-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-(morpholin-4-ylmethyl)phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C(C=C1)=CC=C1CN1CCOCC1 SSXVUQNBYOWXNP-UHFFFAOYSA-N 0.000 claims 1
- BZRROWGMXIIJNF-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-[(2-methylpropylamino)methyl]phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(CNCC(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 BZRROWGMXIIJNF-UHFFFAOYSA-N 0.000 claims 1
- COKBCNBCYPSBSO-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-[(cyclopropylmethylamino)methyl]phenyl]-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C(C=C1)=CC=C1CNCC1CC1 COKBCNBCYPSBSO-UHFFFAOYSA-N 0.000 claims 1
- LNVUMXKSQYMVSZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-6-oxo-9-phenyl-2-[4-(trifluoromethyl)phenyl]purine-8-carbonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=C(C#N)N2C1=CC=CC=C1 LNVUMXKSQYMVSZ-UHFFFAOYSA-N 0.000 claims 1
- ZRDOXHXOEKLHLM-UHFFFAOYSA-N 1-(4-chlorophenyl)-8-(dimethylamino)-9-phenyl-2-[4-(trifluoromethyl)phenyl]purin-6-one Chemical compound C=1C=CC=CC=1N1C(N(C)C)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(C(F)(F)F)C=C1 ZRDOXHXOEKLHLM-UHFFFAOYSA-N 0.000 claims 1
- HDXCZNTUUOXXIA-UHFFFAOYSA-N 1-(4-chlorophenyl)-8-(methylsulfonylmethyl)-9-phenyl-2-(4-phenylphenyl)purin-6-one Chemical compound C=1C=CC=CC=1N1C(CS(=O)(=O)C)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C(C=C1)=CC=C1C1=CC=CC=C1 HDXCZNTUUOXXIA-UHFFFAOYSA-N 0.000 claims 1
- GLAABERGSQZJGM-UHFFFAOYSA-N 1-(4-chlorophenyl)-8-[ethyl(methyl)amino]-9-phenyl-2-[4-(trifluoromethyl)phenyl]purin-6-one Chemical compound C=1C=CC=CC=1N1C(N(C)CC)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(C(F)(F)F)C=C1 GLAABERGSQZJGM-UHFFFAOYSA-N 0.000 claims 1
- BYBHJBWVKGKHQS-UHFFFAOYSA-N 1-(4-chlorophenyl)-8-ethyl-9-phenyl-2-(4-phenylphenyl)purin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C(C=C1)=CC=C1C1=CC=CC=C1 BYBHJBWVKGKHQS-UHFFFAOYSA-N 0.000 claims 1
- BODVBOCQUXLMLO-UHFFFAOYSA-N 1-(4-chlorophenyl)-8-ethyl-9-phenyl-2-[4-(trifluoromethyl)phenyl]purin-6-one Chemical compound C=1C=CC=CC=1N1C(CC)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C1=CC=C(C(F)(F)F)C=C1 BODVBOCQUXLMLO-UHFFFAOYSA-N 0.000 claims 1
- GBQLYPPBCWUOFS-UHFFFAOYSA-N 1-(4-chlorophenyl)-8-methyl-9-phenyl-2-(4-phenylphenyl)purin-6-one Chemical compound C=1C=CC=CC=1N1C(C)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C(C=C1)=CC=C1C1=CC=CC=C1 GBQLYPPBCWUOFS-UHFFFAOYSA-N 0.000 claims 1
- WHZPNOYXUAFHJD-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-(2-methoxy-5-methylphenyl)-2-(4-phenylphenyl)purin-6-one Chemical compound COC1=CC=C(C)C=C1N1C(N=C(C=2C=CC(=CC=2)C=2C=CC=CC=2)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 WHZPNOYXUAFHJD-UHFFFAOYSA-N 0.000 claims 1
- PUGXRTCMYZURKL-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-(4-methylphenyl)-2-(4-phenylphenyl)purin-6-one Chemical compound C1=CC(C)=CC=C1N1C(N=C(C=2C=CC(=CC=2)C=2C=CC=CC=2)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 PUGXRTCMYZURKL-UHFFFAOYSA-N 0.000 claims 1
- LVZLXCFGFYLFKW-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-cyclopropyl-2-(4-phenylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C3CC3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 LVZLXCFGFYLFKW-UHFFFAOYSA-N 0.000 claims 1
- LCCHHIBJDZURRV-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-phenylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 LCCHHIBJDZURRV-UHFFFAOYSA-N 0.000 claims 1
- NUJWVWFVVNKWEW-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-propan-2-ylphenyl)purin-6-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 NUJWVWFVVNKWEW-UHFFFAOYSA-N 0.000 claims 1
- ZCKJNYMEOFPEIB-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-propylphenyl)purin-6-one Chemical compound C1=CC(CCC)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 ZCKJNYMEOFPEIB-UHFFFAOYSA-N 0.000 claims 1
- LSILAWNOINUOIN-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-pyrazol-1-ylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2N=CC=C2)C=C1 LSILAWNOINUOIN-UHFFFAOYSA-N 0.000 claims 1
- WBEAEJQTWKUKEH-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-pyridin-2-ylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2N=CC=CC=2)C=C1 WBEAEJQTWKUKEH-UHFFFAOYSA-N 0.000 claims 1
- BHIFUCOXDGXAMK-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-pyridin-3-ylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=NC=CC=2)C=C1 BHIFUCOXDGXAMK-UHFFFAOYSA-N 0.000 claims 1
- RWVSPZGSKDCFTL-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-pyridin-4-ylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CN=CC=2)C=C1 RWVSPZGSKDCFTL-UHFFFAOYSA-N 0.000 claims 1
- OPOQCSIYRBSSBR-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-(4-thiophen-3-ylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2=CSC=C2)C=C1 OPOQCSIYRBSSBR-UHFFFAOYSA-N 0.000 claims 1
- QJBAKMRVRAHLIY-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-[4-(piperidin-1-ylmethyl)phenyl]purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C(C=C1)=CC=C1CN1CCCCC1 QJBAKMRVRAHLIY-UHFFFAOYSA-N 0.000 claims 1
- VEKGCUXNOUIBNQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-[4-(propan-2-yloxymethyl)phenyl]purin-6-one Chemical compound C1=CC(COC(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 VEKGCUXNOUIBNQ-UHFFFAOYSA-N 0.000 claims 1
- FBDYQWZZSYFJRW-UHFFFAOYSA-N 1-(4-chlorophenyl)-9-phenyl-2-[4-(trifluoromethyl)phenyl]purin-6-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 FBDYQWZZSYFJRW-UHFFFAOYSA-N 0.000 claims 1
- RLWPABNJWZXKOE-UHFFFAOYSA-N 1-[4-(trifluoromethyl)phenyl]-7H-purin-6-one Chemical compound FC(C1=CC=C(C=C1)N1C=NC=2N=CNC=2C1=O)(F)F RLWPABNJWZXKOE-UHFFFAOYSA-N 0.000 claims 1
- CRJHVYHTWFSRSZ-UHFFFAOYSA-N 1-phenyl-6-(4-propan-2-ylphenyl)-5-[3-(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(C=CC=2)C(F)(F)F)=NC2=C1C=NN2C1=CC=CC=C1 CRJHVYHTWFSRSZ-UHFFFAOYSA-N 0.000 claims 1
- XOORDSFVLQZWDQ-UHFFFAOYSA-N 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-7-phenylpurin-6-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C(N(C=2C=CC=CC=2)C=N2)=C2N=C1C1=CC=C(Br)C=C1 XOORDSFVLQZWDQ-UHFFFAOYSA-N 0.000 claims 1
- AUFHOPBIGBWDCS-UHFFFAOYSA-N 2-(4-bromophenyl)-1-(4-chlorophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 AUFHOPBIGBWDCS-UHFFFAOYSA-N 0.000 claims 1
- ZKGOTJDYYKPBAV-UHFFFAOYSA-N 2-(4-butoxyphenyl)-1-(4-chlorophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(OCCCC)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 ZKGOTJDYYKPBAV-UHFFFAOYSA-N 0.000 claims 1
- UESYWYKKRUYZFE-UHFFFAOYSA-N 2-(4-chloro-2-fluorophenyl)-1-(4-chlorophenyl)-9-phenylpurin-6-one Chemical compound FC1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 UESYWYKKRUYZFE-UHFFFAOYSA-N 0.000 claims 1
- WBOQBXAJVGODIT-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-(2-fluorophenyl)-7-phenylpurin-6-one Chemical compound FC1=CC=CC=C1N1C(=O)C(N(C=2C=CC=CC=2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1 WBOQBXAJVGODIT-UHFFFAOYSA-N 0.000 claims 1
- CSICFTUOUCJDJH-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-(4-methoxyphenyl)-7-phenylpurin-6-one Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(N(C=2C=CC=CC=2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1 CSICFTUOUCJDJH-UHFFFAOYSA-N 0.000 claims 1
- LVJSAYGXAGEWQL-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-(4-methylphenyl)-7-phenylpurin-6-one Chemical compound C1=CC(C)=CC=C1N1C(=O)C(N(C=2C=CC=CC=2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1 LVJSAYGXAGEWQL-UHFFFAOYSA-N 0.000 claims 1
- UGQBRSYOCBLADL-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[4-(2-fluorophenyl)phenyl]-7-phenylpurin-6-one Chemical compound FC1=CC=CC=C1C1=CC=C(N2C(C=3N(C=4C=CC=CC=4)C=NC=3N=C2C=2C=CC(Cl)=CC=2)=O)C=C1 UGQBRSYOCBLADL-UHFFFAOYSA-N 0.000 claims 1
- GFBVBTPWGMKIQJ-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[4-(3-fluorophenyl)phenyl]-7-phenylpurin-6-one Chemical compound FC1=CC=CC(C=2C=CC(=CC=2)N2C(C=3N(C=4C=CC=CC=4)C=NC=3N=C2C=2C=CC(Cl)=CC=2)=O)=C1 GFBVBTPWGMKIQJ-UHFFFAOYSA-N 0.000 claims 1
- HXORJXWSXRVNIH-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[4-(4-fluorophenyl)phenyl]-7-phenylpurin-6-one Chemical compound C1=CC(F)=CC=C1C1=CC=C(N2C(C=3N(C=4C=CC=CC=4)C=NC=3N=C2C=2C=CC(Cl)=CC=2)=O)C=C1 HXORJXWSXRVNIH-UHFFFAOYSA-N 0.000 claims 1
- SKLPGWALCXEOTH-UHFFFAOYSA-N 2-(4-chlorophenyl)-7-phenyl-1-(4-phenylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)=NC2=C1N(C=1C=CC=CC=1)C=N2 SKLPGWALCXEOTH-UHFFFAOYSA-N 0.000 claims 1
- CSXYMNWOQOGRDH-UHFFFAOYSA-N 2-(4-chlorophenyl)-7-phenyl-1-(4-propan-2-ylphenyl)purin-6-one Chemical compound C1=CC(C(C)C)=CC=C1N1C(=O)C(N(C=2C=CC=CC=2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1 CSXYMNWOQOGRDH-UHFFFAOYSA-N 0.000 claims 1
- QWNKKHUSUXFFIW-UHFFFAOYSA-N 2-[1-[4-[5-(4-chlorophenyl)-4-oxo-1-phenylpyrazolo[3,4-d]pyrimidin-6-yl]phenyl]imidazol-4-yl]acetonitrile Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2C=C(CC#N)N=C2)C=C1 QWNKKHUSUXFFIW-UHFFFAOYSA-N 0.000 claims 1
- ILTJFHCMDXYBCB-UHFFFAOYSA-N 2-[4-(6-aminopyridin-3-yl)phenyl]-1-(4-chlorophenyl)-9-phenylpurin-6-one Chemical compound C1=NC(N)=CC=C1C1=CC=C(C=2N(C(=O)C=3N=CN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 ILTJFHCMDXYBCB-UHFFFAOYSA-N 0.000 claims 1
- RUSFGTZYRAYLLD-UHFFFAOYSA-N 2-[4-(chloromethyl)phenyl]-1-(4-chlorophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(CCl)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N=CN2C1=CC=CC=C1 RUSFGTZYRAYLLD-UHFFFAOYSA-N 0.000 claims 1
- YCMBLHVJLJWCRH-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)-7-oxo-3-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[4,3-d]pyrimidin-1-yl]acetamide Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N(CC(N)=O)N=C2C1=CC=CC=C1 YCMBLHVJLJWCRH-UHFFFAOYSA-N 0.000 claims 1
- ACGZVOALBQCNGX-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)-7-oxo-3-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[4,3-d]pyrimidin-1-yl]acetonitrile Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N(CC#N)N=C2C1=CC=CC=C1 ACGZVOALBQCNGX-UHFFFAOYSA-N 0.000 claims 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims 1
- YATFTUJZIJFLJA-UHFFFAOYSA-N 3-[1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-9-yl]benzonitrile Chemical compound ClC1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC(C#N)=C1 YATFTUJZIJFLJA-UHFFFAOYSA-N 0.000 claims 1
- TZBKUSCZXKRNHN-UHFFFAOYSA-N 3-[1-(4-bromophenyl)-2-(4-methylphenyl)-6-oxopurin-9-yl]benzonitrile Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=CC(C#N)=C1 TZBKUSCZXKRNHN-UHFFFAOYSA-N 0.000 claims 1
- UGQKWJSXWJEJGM-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-7-yl]benzoic acid Chemical compound ClC1=CC=C(C=C1)N1C(=NC=2N=CN(C2C1=O)C=1C=C(C(=O)O)C=CC1)C1=C(C=C(C=C1)Cl)Cl UGQKWJSXWJEJGM-UHFFFAOYSA-N 0.000 claims 1
- SXAVMQSSGMEVFA-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-7-yl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(C=2C=C(C=CC=2)C#N)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl SXAVMQSSGMEVFA-UHFFFAOYSA-N 0.000 claims 1
- QCPRLXOQQKSTCL-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-9-yl]benzoic acid Chemical compound ClC1=CC=C(C=C1)N1C(=NC=2N(C=NC2C1=O)C=1C=C(C(=O)O)C=CC1)C1=C(C=C(C=C1)Cl)Cl QCPRLXOQQKSTCL-UHFFFAOYSA-N 0.000 claims 1
- WTOCCEGGUHWXJT-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-9-yl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=C(C=CC=3)C#N)=C2N=C1C1=CC=C(Cl)C=C1Cl WTOCCEGGUHWXJT-UHFFFAOYSA-N 0.000 claims 1
- XLGMFZWHFVYQGO-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-6-oxo-2-(4-phenylphenyl)purin-9-yl]-n-(1,2-oxazol-3-yl)benzamide Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=C(C=CC=3)C(=O)NC3=NOC=C3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 XLGMFZWHFVYQGO-UHFFFAOYSA-N 0.000 claims 1
- MRIROVMMYNXUDN-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-6-oxo-2-(4-phenylphenyl)purin-9-yl]-n-cyclohexylbenzamide Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=C(C=CC=3)C(=O)NC3CCCCC3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 MRIROVMMYNXUDN-UHFFFAOYSA-N 0.000 claims 1
- MUEKLPGQALHWCB-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-6-oxo-2-(4-phenylphenyl)purin-9-yl]-n-cyclopropylbenzamide Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=C(C=CC=3)C(=O)NC3CC3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 MUEKLPGQALHWCB-UHFFFAOYSA-N 0.000 claims 1
- RKJHJWUHTWZJJP-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-6-oxo-2-(4-phenylphenyl)purin-9-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C=CC(=CC=4)C=4C=CC=CC=4)=N3)=O)N=C2)=C1 RKJHJWUHTWZJJP-UHFFFAOYSA-N 0.000 claims 1
- NWDBLMYZRUXXHB-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-6-oxo-2-(4-phenylphenyl)purin-9-yl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=C(C=CC=3)C#N)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 NWDBLMYZRUXXHB-UHFFFAOYSA-N 0.000 claims 1
- ZPKVIEXMKCELML-UHFFFAOYSA-N 3-[4-[5-(4-chlorophenyl)-4-oxo-1-phenylpyrazolo[3,4-d]pyrimidin-6-yl]phenyl]pyrazine-2-carbonitrile Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C(=NC=CN=2)C#N)C=C1 ZPKVIEXMKCELML-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- UTJBCFUJHFHCPQ-UHFFFAOYSA-N 4-[1-(4-bromophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-9-yl]benzonitrile Chemical compound ClC1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=CN2C1=CC=C(C#N)C=C1 UTJBCFUJHFHCPQ-UHFFFAOYSA-N 0.000 claims 1
- FJNBWQBAKPBELM-UHFFFAOYSA-N 4-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-7-yl]-n-cyclopropylbenzamide Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(C=2C=CC(=CC=2)C(=O)NC2CC2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl FJNBWQBAKPBELM-UHFFFAOYSA-N 0.000 claims 1
- ZFGTUOISGBTCSJ-UHFFFAOYSA-N 4-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-7-yl]benzoic acid Chemical compound ClC1=CC=C(C=C1)N1C(=NC=2N=CN(C2C1=O)C1=CC=C(C(=O)O)C=C1)C1=C(C=C(C=C1)Cl)Cl ZFGTUOISGBTCSJ-UHFFFAOYSA-N 0.000 claims 1
- JFFGTDYJHHBJSF-UHFFFAOYSA-N 4-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-9-yl]-n-cyclopropylbenzamide Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC(=CC=3)C(=O)NC3CC3)=C2N=C1C1=CC=C(Cl)C=C1Cl JFFGTDYJHHBJSF-UHFFFAOYSA-N 0.000 claims 1
- BGNMDHBWZVITDU-UHFFFAOYSA-N 4-[1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-6-oxopurin-9-yl]benzoic acid Chemical compound ClC1=CC=C(C=C1)N1C(=NC=2N(C=NC2C1=O)C1=CC=C(C(=O)O)C=C1)C1=C(C=C(C=C1)Cl)Cl BGNMDHBWZVITDU-UHFFFAOYSA-N 0.000 claims 1
- QFRADVTVYKLBIM-UHFFFAOYSA-N 4-[1-(4-chlorophenyl)-6-oxo-2-(4-phenylphenyl)purin-9-yl]benzonitrile Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2C=3C=CC(=CC=3)C#N)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 QFRADVTVYKLBIM-UHFFFAOYSA-N 0.000 claims 1
- GFYWJAULQMFBNF-UHFFFAOYSA-N 4-[2-[5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-phenylpyrazolo[3,4-b]pyridin-4-yl]oxyethyl]morpholine Chemical compound C1=CC(Cl)=CC=C1C(C(=NC=1N(C=2C=CC=CC=2)N=CC=11)C=2C(=CC(Cl)=CC=2)Cl)=C1OCCN1CCOCC1 GFYWJAULQMFBNF-UHFFFAOYSA-N 0.000 claims 1
- YQNBEYXRSHNTTN-UHFFFAOYSA-N 4-[3-[5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-phenylpyrazolo[3,4-b]pyridin-4-yl]oxypropyl]morpholine Chemical compound C1=CC(Cl)=CC=C1C(C(=NC=1N(C=2C=CC=CC=2)N=CC=11)C=2C(=CC(Cl)=CC=2)Cl)=C1OCCCN1CCOCC1 YQNBEYXRSHNTTN-UHFFFAOYSA-N 0.000 claims 1
- QFIVFINKWOVMNI-UHFFFAOYSA-N 4-[5-(4-bromophenyl)-6-(2-fluorophenyl)-4-oxopyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=C(C#N)C=C1 QFIVFINKWOVMNI-UHFFFAOYSA-N 0.000 claims 1
- QADRWQDDMAOCAU-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-4-oxopyrazolo[3,4-d]pyrimidin-1-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 QADRWQDDMAOCAU-UHFFFAOYSA-N 0.000 claims 1
- JDDVRJUYXRYOMX-UHFFFAOYSA-N 4-[6-(2-fluorophenyl)-4-oxo-1-phenylpyrazolo[3,4-d]pyrimidin-5-yl]benzonitrile Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(=CC=2)C#N)=NC2=C1C=NN2C1=CC=CC=C1 JDDVRJUYXRYOMX-UHFFFAOYSA-N 0.000 claims 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- HLYRSBSWPJDADE-UHFFFAOYSA-N 5,6-bis(2-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1C(N(C1=O)C=2C(=CC=CC=2)C)=NC2=C1C=NN2C1=CC=CC=C1 HLYRSBSWPJDADE-UHFFFAOYSA-N 0.000 claims 1
- GDHPGXMZIAFXCN-UHFFFAOYSA-N 5,6-bis(4-bromophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Br)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 GDHPGXMZIAFXCN-UHFFFAOYSA-N 0.000 claims 1
- FUZACIKGBXSFJQ-UHFFFAOYSA-N 5,6-bis(4-chlorophenyl)-1-(2-nitrophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound [O-][N+](=O)C1=CC=CC=C1N1C(N=C(C=2C=CC(Cl)=CC=2)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 FUZACIKGBXSFJQ-UHFFFAOYSA-N 0.000 claims 1
- PWPNBHRDSFLVJM-UHFFFAOYSA-N 5,6-bis(4-chlorophenyl)-1-(4-nitrophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1C(N=C(C=2C=CC(Cl)=CC=2)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 PWPNBHRDSFLVJM-UHFFFAOYSA-N 0.000 claims 1
- VXDBYEDOONMQMV-UHFFFAOYSA-N 5,6-bis(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 VXDBYEDOONMQMV-UHFFFAOYSA-N 0.000 claims 1
- LMHVDFBVZZVLES-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C(=CC(Cl)=CC=2)Cl)=NC2=C1C=NN2C1=CC=CC=C1 LMHVDFBVZZVLES-UHFFFAOYSA-N 0.000 claims 1
- BUSHPLPJLFMRIS-UHFFFAOYSA-N 5-(2-methylphenyl)-1,6-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1 BUSHPLPJLFMRIS-UHFFFAOYSA-N 0.000 claims 1
- QDMNYILTVWAKSY-UHFFFAOYSA-N 5-(2-methylphenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C(=CC=CC=2)C)=NC2=C1C=NN2C1=CC=CC=C1 QDMNYILTVWAKSY-UHFFFAOYSA-N 0.000 claims 1
- VNXYMRGUVGKAEO-UHFFFAOYSA-N 5-(3,4-dichlorophenyl)-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(Cl)C(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 VNXYMRGUVGKAEO-UHFFFAOYSA-N 0.000 claims 1
- YOCVZALTYMVTEN-UHFFFAOYSA-N 5-(3,5-difluorophenyl)-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(F)C=C(F)C=2)=NC2=C1C=NN2C1=CC=CC=C1 YOCVZALTYMVTEN-UHFFFAOYSA-N 0.000 claims 1
- KCWFJYYAHVXYOS-UHFFFAOYSA-N 5-(3-bromophenyl)-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(Br)C=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 KCWFJYYAHVXYOS-UHFFFAOYSA-N 0.000 claims 1
- WPYGRQTXWXUSEV-UHFFFAOYSA-N 5-(3-chlorophenyl)-1,6-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound ClC1=CC=CC(N2C(C=3C=NN(C=3N=C2C=2C=CC=CC=2)C=2C=CC=CC=2)=O)=C1 WPYGRQTXWXUSEV-UHFFFAOYSA-N 0.000 claims 1
- VXBFAPWVPLPMIO-UHFFFAOYSA-N 5-(3-chlorophenyl)-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(Cl)C=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 VXBFAPWVPLPMIO-UHFFFAOYSA-N 0.000 claims 1
- CWRJPIDSWJRJIT-UHFFFAOYSA-N 5-(3-chlorophenyl)-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=C(Cl)C=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 CWRJPIDSWJRJIT-UHFFFAOYSA-N 0.000 claims 1
- AROPKPIERSUSNA-UHFFFAOYSA-N 5-(3-chlorophenyl)-6-(3-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=C(Cl)C=CC=2)=C1 AROPKPIERSUSNA-UHFFFAOYSA-N 0.000 claims 1
- BREBHAMOAQDITI-UHFFFAOYSA-N 5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=C(Cl)C=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 BREBHAMOAQDITI-UHFFFAOYSA-N 0.000 claims 1
- PFIRLQMLQPBDIH-UHFFFAOYSA-N 5-(3-chlorophenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=C(Cl)C=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 PFIRLQMLQPBDIH-UHFFFAOYSA-N 0.000 claims 1
- RBUNIMSMKPACJI-UHFFFAOYSA-N 5-(3-fluorophenyl)-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(F)C=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 RBUNIMSMKPACJI-UHFFFAOYSA-N 0.000 claims 1
- YWXLLWNVTQDKIP-UHFFFAOYSA-N 5-(3-methylphenyl)-1,6-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(N2C(C=3C=NN(C=3N=C2C=2C=CC=CC=2)C=2C=CC=CC=2)=O)=C1 YWXLLWNVTQDKIP-UHFFFAOYSA-N 0.000 claims 1
- VYAWBLGXLRIJAH-UHFFFAOYSA-N 5-(3-methylphenyl)-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(C)C=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 VYAWBLGXLRIJAH-UHFFFAOYSA-N 0.000 claims 1
- JMEWNABJMKGPPW-UHFFFAOYSA-N 5-(4-bromophenyl)-1,6-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Br)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1 JMEWNABJMKGPPW-UHFFFAOYSA-N 0.000 claims 1
- GRDXZYNLJSIJFS-UHFFFAOYSA-N 5-(4-bromophenyl)-1-(1,1-dioxothian-4-yl)-6-(2-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1CCS(=O)(=O)CC1 GRDXZYNLJSIJFS-UHFFFAOYSA-N 0.000 claims 1
- IKAKSZRLDRHKKV-UHFFFAOYSA-N 5-(4-bromophenyl)-1-cyclohexyl-6-(2-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1CCCCC1 IKAKSZRLDRHKKV-UHFFFAOYSA-N 0.000 claims 1
- YNZXYZUXKYNUSM-UHFFFAOYSA-N 5-(4-bromophenyl)-1-phenyl-6-(2,4,6-trifluorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(F)=CC(F)=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 YNZXYZUXKYNUSM-UHFFFAOYSA-N 0.000 claims 1
- VMEPLDPNGMZKAK-UHFFFAOYSA-N 5-(4-bromophenyl)-1-phenyl-6-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Br)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1N1CCN(C=2C=CC=CC=2)CC1 VMEPLDPNGMZKAK-UHFFFAOYSA-N 0.000 claims 1
- MCGQLFVVGDCBMG-UHFFFAOYSA-N 5-(4-bromophenyl)-1-phenyl-6-(4-propan-2-ylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1CN(C(C)C)CCN1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 MCGQLFVVGDCBMG-UHFFFAOYSA-N 0.000 claims 1
- HJNRDAPPYFBISY-UHFFFAOYSA-N 5-(4-bromophenyl)-1-phenyl-6-[2-(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC(F)(F)C1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 HJNRDAPPYFBISY-UHFFFAOYSA-N 0.000 claims 1
- NLGYFLWYGHTFDA-UHFFFAOYSA-N 5-(4-bromophenyl)-1-phenyl-6-[4-(trifluoromethoxy)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OC(F)(F)F)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 NLGYFLWYGHTFDA-UHFFFAOYSA-N 0.000 claims 1
- RJSHELDJUSGJSA-UHFFFAOYSA-N 5-(4-bromophenyl)-1-phenyl-6-[4-(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 RJSHELDJUSGJSA-UHFFFAOYSA-N 0.000 claims 1
- UUPNPRGFKWHLKH-UHFFFAOYSA-N 5-(4-bromophenyl)-1-phenyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Br)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CN=C1 UUPNPRGFKWHLKH-UHFFFAOYSA-N 0.000 claims 1
- ALJWCMHENAOSCQ-UHFFFAOYSA-N 5-(4-bromophenyl)-1-tert-butyl-6-(2-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC(C)(C)N1N=CC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=CC=C1F ALJWCMHENAOSCQ-UHFFFAOYSA-N 0.000 claims 1
- NRSAYQXHPVMSKO-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2,4-dichlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound ClC1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 NRSAYQXHPVMSKO-UHFFFAOYSA-N 0.000 claims 1
- CCSUCWGIPXGSDF-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2,4-dichlorophenyl)-3-methylsulfanyl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C(=CC(Cl)=CC=3)Cl)N(C=3C=CC(Br)=CC=3)C(=O)C=2C(SC)=NN1C1=CC=CC=C1 CCSUCWGIPXGSDF-UHFFFAOYSA-N 0.000 claims 1
- VKJHBONZDGPMAS-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2,4-dichlorophenyl)-3-methylsulfonyl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C(=CC(Cl)=CC=3)Cl)N(C=3C=CC(Br)=CC=3)C(=O)C=2C(S(=O)(=O)C)=NN1C1=CC=CC=C1 VKJHBONZDGPMAS-UHFFFAOYSA-N 0.000 claims 1
- OEBJBLRPUYANKO-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2,4-difluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(F)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 OEBJBLRPUYANKO-UHFFFAOYSA-N 0.000 claims 1
- BYKAAIRKYWYTMK-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2,6-dichlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound ClC1=CC=CC(Cl)=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 BYKAAIRKYWYTMK-UHFFFAOYSA-N 0.000 claims 1
- SWQMAJZBSKXELP-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2,6-difluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC(F)=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 SWQMAJZBSKXELP-UHFFFAOYSA-N 0.000 claims 1
- FOUGBFGIJMJMHB-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound ClC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 FOUGBFGIJMJMHB-UHFFFAOYSA-N 0.000 claims 1
- LTNPJQLFYHCNGF-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-(2-hydroxyethyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound OCCN1N=CC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=CC=C1F LTNPJQLFYHCNGF-UHFFFAOYSA-N 0.000 claims 1
- VDWIKOJRKBDQEE-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-(3-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC(N2C3=C(C(N(C=4C=CC(Br)=CC=4)C(C=4C(=CC=CC=4)F)=N3)=O)C=N2)=C1 VDWIKOJRKBDQEE-UHFFFAOYSA-N 0.000 claims 1
- PMUNRDRLQSYQSU-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-(4-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1N1C(N=C(C=2C(=CC=CC=2)F)N(C=2C=CC(Br)=CC=2)C2=O)=C2C=N1 PMUNRDRLQSYQSU-UHFFFAOYSA-N 0.000 claims 1
- NYBVWEFWLFHTAB-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-(morpholine-4-carbonyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C(=O)N1CCOCC1 NYBVWEFWLFHTAB-UHFFFAOYSA-N 0.000 claims 1
- XOFXVDPQECDIOV-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-(oxan-4-yl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1CCOCC1 XOFXVDPQECDIOV-UHFFFAOYSA-N 0.000 claims 1
- YPGHVKQSXGSYKD-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-(thian-4-yl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1CCSCC1 YPGHVKQSXGSYKD-UHFFFAOYSA-N 0.000 claims 1
- JZWNLPCLDXNWAP-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-[4-(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=C(C(F)(F)F)C=C1 JZWNLPCLDXNWAP-UHFFFAOYSA-N 0.000 claims 1
- OKSWCQBDBKHZOG-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CN1N=CC(C(N2C=3C=CC(Br)=CC=3)=O)=C1N=C2C1=CC=CC=C1F OKSWCQBDBKHZOG-UHFFFAOYSA-N 0.000 claims 1
- AENVNGDHIIEYHT-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 AENVNGDHIIEYHT-UHFFFAOYSA-N 0.000 claims 1
- UNQVGQBMTIXWHG-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=N1 UNQVGQBMTIXWHG-UHFFFAOYSA-N 0.000 claims 1
- CLQISLUXROVCLW-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-fluorophenyl)-1-quinolin-2-ylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=C(C=CC=C2)C2=N1 CLQISLUXROVCLW-UHFFFAOYSA-N 0.000 claims 1
- WFIJVPDVGTUQAK-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-methoxyphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound COC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 WFIJVPDVGTUQAK-UHFFFAOYSA-N 0.000 claims 1
- WXGNKFJLXNBNME-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 WXGNKFJLXNBNME-UHFFFAOYSA-N 0.000 claims 1
- CDRGMJUORSCGTH-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(2-methylphenyl)-1-pyridin-2-ylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=N1 CDRGMJUORSCGTH-UHFFFAOYSA-N 0.000 claims 1
- HRLWAFQSMMQELZ-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(3,4-dichlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 HRLWAFQSMMQELZ-UHFFFAOYSA-N 0.000 claims 1
- JZTNHBLCQUUIJA-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(3-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound ClC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1 JZTNHBLCQUUIJA-UHFFFAOYSA-N 0.000 claims 1
- MIWBSZXTENKDNP-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(3-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1 MIWBSZXTENKDNP-UHFFFAOYSA-N 0.000 claims 1
- MNJDBHHGQPLUDS-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(3-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)=C1 MNJDBHHGQPLUDS-UHFFFAOYSA-N 0.000 claims 1
- WIUCPYCEYTYWDM-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-chlorophenyl)-1-methyl-3-phenylpyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=2N=C(C=3C=CC(Br)=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2N(C)N=C1C1=CC=CC=C1 WIUCPYCEYTYWDM-UHFFFAOYSA-N 0.000 claims 1
- SGGJKJSDGNSNJN-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-chlorophenyl)-1-methylsulfonyl-3-phenylpyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=2N=C(C=3C=CC(Br)=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2N(S(=O)(=O)C)N=C1C1=CC=CC=C1 SGGJKJSDGNSNJN-UHFFFAOYSA-N 0.000 claims 1
- KCSXPQZNRWZJTJ-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 KCSXPQZNRWZJTJ-UHFFFAOYSA-N 0.000 claims 1
- DRMHLXRMPCRKLA-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-chlorophenyl)-3-phenyl-1h-pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(NN=C2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 DRMHLXRMPCRKLA-UHFFFAOYSA-N 0.000 claims 1
- GVCQZIWKXNNQLH-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 GVCQZIWKXNNQLH-UHFFFAOYSA-N 0.000 claims 1
- JNJJJAIZOSVPRC-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-methoxyphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 JNJJJAIZOSVPRC-UHFFFAOYSA-N 0.000 claims 1
- OBSGRCRYWAXULL-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 OBSGRCRYWAXULL-UHFFFAOYSA-N 0.000 claims 1
- FZOKQOPSDIUYKU-UHFFFAOYSA-N 5-(4-bromophenyl)-6-(4-tert-butylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)(C)C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 FZOKQOPSDIUYKU-UHFFFAOYSA-N 0.000 claims 1
- MGNLIZFEFJJQPJ-UHFFFAOYSA-N 5-(4-bromophenyl)-6-[4-(4-fluorophenyl)piperazin-1-yl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1N1CCN(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Br)=CC=2)CC1 MGNLIZFEFJJQPJ-UHFFFAOYSA-N 0.000 claims 1
- WYTOQKHOLMVLBZ-UHFFFAOYSA-N 5-(4-bromophenyl)-6-morpholin-4-yl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Br)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1N1CCOCC1 WYTOQKHOLMVLBZ-UHFFFAOYSA-N 0.000 claims 1
- JCBYGXZQZIBSJB-UHFFFAOYSA-N 5-(4-butoxyphenyl)-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OCCCC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F JCBYGXZQZIBSJB-UHFFFAOYSA-N 0.000 claims 1
- JYRKWNNWEOGAEQ-UHFFFAOYSA-N 5-(4-chloro-2-fluorophenyl)-6-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1 JYRKWNNWEOGAEQ-UHFFFAOYSA-N 0.000 claims 1
- KHWFRSPWMBNHPH-UHFFFAOYSA-N 5-(4-chloro-3-methylphenyl)-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=C(C)C(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 KHWFRSPWMBNHPH-UHFFFAOYSA-N 0.000 claims 1
- XZEULPBGZKKVGC-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-(oxan-4-yl)-6-(4-phenylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C3CCOCC3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 XZEULPBGZKKVGC-UHFFFAOYSA-N 0.000 claims 1
- UJATXPNEQQRLDP-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-phenylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 UJATXPNEQQRLDP-UHFFFAOYSA-N 0.000 claims 1
- FUXHFUZLVSJXKQ-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1N1CCN(C=2C=CC=CC=2)CC1 FUXHFUZLVSJXKQ-UHFFFAOYSA-N 0.000 claims 1
- VSRRMKVVIOQQHC-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-piperidin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2CCCCC2)C=C1 VSRRMKVVIOQQHC-UHFFFAOYSA-N 0.000 claims 1
- NEFOOJZAPHPRBP-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyrazin-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2N=CC=NC=2)C=C1 NEFOOJZAPHPRBP-UHFFFAOYSA-N 0.000 claims 1
- PIQOWPRRCULDDD-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyrazol-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2N=CC=C2)C=C1 PIQOWPRRCULDDD-UHFFFAOYSA-N 0.000 claims 1
- FBYFRFMYNJRAII-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyridazin-3-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2N=NC=CC=2)C=C1 FBYFRFMYNJRAII-UHFFFAOYSA-N 0.000 claims 1
- LXVUPOZOCZCPRG-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyridin-2-ylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1N1CCN(C=2N=CC=CC=2)CC1 LXVUPOZOCZCPRG-UHFFFAOYSA-N 0.000 claims 1
- PHUDPJVYKAMFLB-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyridin-3-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=NC=CC=2)C=C1 PHUDPJVYKAMFLB-UHFFFAOYSA-N 0.000 claims 1
- MVGZQHBNCHWICT-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyridin-4-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CN=CC=2)C=C1 MVGZQHBNCHWICT-UHFFFAOYSA-N 0.000 claims 1
- KGFQWMXEDVCLOH-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyridin-4-ylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1N1CCN(C=2C=CN=CC=2)CC1 KGFQWMXEDVCLOH-UHFFFAOYSA-N 0.000 claims 1
- LRLOWWKGVXPFTP-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyrimidin-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2N=CC=CN=2)C=C1 LRLOWWKGVXPFTP-UHFFFAOYSA-N 0.000 claims 1
- LCOWGKUNACIEMB-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-pyrimidin-4-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2N=CN=CC=2)C=C1 LCOWGKUNACIEMB-UHFFFAOYSA-N 0.000 claims 1
- MSMRRMVLQSMLAF-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-(4-thiophen-3-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2=CSC=C2)C=C1 MSMRRMVLQSMLAF-UHFFFAOYSA-N 0.000 claims 1
- NHDVULQHKIETPA-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-[4-(1h-pyrazol-5-yl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2NN=CC=2)C=C1 NHDVULQHKIETPA-UHFFFAOYSA-N 0.000 claims 1
- ZIVDTPSEPAUQHH-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-[4-(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 ZIVDTPSEPAUQHH-UHFFFAOYSA-N 0.000 claims 1
- MEDKQSKIMGKDJT-UHFFFAOYSA-N 5-(4-chlorophenyl)-1-phenyl-6-[4-[4-(trifluoromethyl)phenyl]phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 MEDKQSKIMGKDJT-UHFFFAOYSA-N 0.000 claims 1
- BYYPHJDVWJEWNI-UHFFFAOYSA-N 5-(4-chlorophenyl)-3-methylsulfonyl-1-phenyl-6-(4-pyridin-4-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C=CC(=CC=3)C=3C=CN=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(S(=O)(=O)C)=NN1C1=CC=CC=C1 BYYPHJDVWJEWNI-UHFFFAOYSA-N 0.000 claims 1
- QMBNNMQRMJBPSZ-UHFFFAOYSA-N 5-(4-chlorophenyl)-4-oxo-1-phenyl-6-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidine-3-carbonitrile Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C(C#N)=NN2C1=CC=CC=C1 QMBNNMQRMJBPSZ-UHFFFAOYSA-N 0.000 claims 1
- JLGYISOMSXAEKU-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-(4-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 JLGYISOMSXAEKU-UHFFFAOYSA-N 0.000 claims 1
- JYFSAXZZRGLODI-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-(4-nitrophenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 JYFSAXZZRGLODI-UHFFFAOYSA-N 0.000 claims 1
- DUXFJWCJMMVQRG-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-[4-(hydroxymethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(CO)=CC=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2C=N1 DUXFJWCJMMVQRG-UHFFFAOYSA-N 0.000 claims 1
- LJIYIJXXXVCFDS-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-[4-(morpholine-4-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC(=CC=3)C(=O)N3CCOCC3)=C2N=C1C1=CC=C(Cl)C=C1Cl LJIYIJXXXVCFDS-UHFFFAOYSA-N 0.000 claims 1
- NKHCJJRXVRKRCH-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-1-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1CN(C)CCN1CC1=CC=C(N2C3=C(C(N(C=4C=CC(Cl)=CC=4)C(C=4C(=CC(Cl)=CC=4)Cl)=N3)=O)C=N2)C=C1 NKHCJJRXVRKRCH-UHFFFAOYSA-N 0.000 claims 1
- NZFYKIILQAEXGJ-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-3-(4-methylpiperazin-1-yl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1CN(C)CCN1C(C=1C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=NC=11)=NN1C1=CC=CC=C1 NZFYKIILQAEXGJ-UHFFFAOYSA-N 0.000 claims 1
- QDEVMJFEKZUAPB-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-3-methylsulfanyl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C(=CC(Cl)=CC=3)Cl)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(SC)=NN1C1=CC=CC=C1 QDEVMJFEKZUAPB-UHFFFAOYSA-N 0.000 claims 1
- BWZTWEBMIQSBCR-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-3-methylsulfonyl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C(=CC(Cl)=CC=3)Cl)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(S(=O)(=O)C)=NN1C1=CC=CC=C1 BWZTWEBMIQSBCR-UHFFFAOYSA-N 0.000 claims 1
- YJPCCIOXAASMKO-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-4-[2-(4-methylpiperazin-1-yl)ethoxy]-1-phenylpyrazolo[3,4-b]pyridine Chemical compound C1CN(C)CCN1CCOC(C=1C=NN(C=1N=C1C=2C(=CC(Cl)=CC=2)Cl)C=2C=CC=CC=2)=C1C1=CC=C(Cl)C=C1 YJPCCIOXAASMKO-UHFFFAOYSA-N 0.000 claims 1
- KKHWJDKTKHQREG-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2-chloro-4-phenylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1Cl KKHWJDKTKHQREG-UHFFFAOYSA-N 0.000 claims 1
- XLYBSQYGPOELCJ-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2-fluoro-4-morpholin-4-ylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(N2CCOCC2)=CC=C1C1=NC=2N(C=3C=CC=CC=3)N=CC=2C(=O)N1C1=CC=C(Cl)C=C1 XLYBSQYGPOELCJ-UHFFFAOYSA-N 0.000 claims 1
- QCBWYURTADFEAI-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(2-fluoro-4-phenylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(C=2C=CC=CC=2)=CC=C1C1=NC=2N(C=3C=CC=CC=3)N=CC=2C(=O)N1C1=CC=C(Cl)C=C1 QCBWYURTADFEAI-UHFFFAOYSA-N 0.000 claims 1
- IMHKZEZJRDGBQK-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(3-fluoro-4-phenylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=CC=C1C1=CC=CC=C1 IMHKZEZJRDGBQK-UHFFFAOYSA-N 0.000 claims 1
- VRXFDXJDRFCQEU-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(3-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 VRXFDXJDRFCQEU-UHFFFAOYSA-N 0.000 claims 1
- CJNIOJFYSRVPOC-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(4-imidazol-1-ylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2C=NC=C2)C=C1 CJNIOJFYSRVPOC-UHFFFAOYSA-N 0.000 claims 1
- UFWZQNVRLMZAJW-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(4-iodophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(I)C=C1 UFWZQNVRLMZAJW-UHFFFAOYSA-N 0.000 claims 1
- RVQDJZFMMGKQHZ-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 RVQDJZFMMGKQHZ-UHFFFAOYSA-N 0.000 claims 1
- GIOHKSNBXOHGOF-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(4-methylsulfonylpiperazin-1-yl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1CN(S(=O)(=O)C)CCN1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 GIOHKSNBXOHGOF-UHFFFAOYSA-N 0.000 claims 1
- SZUDOMLCODKDDA-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(4-morpholin-4-ylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2CCOCC2)C=C1 SZUDOMLCODKDDA-UHFFFAOYSA-N 0.000 claims 1
- UBTNNQYFMVAWSA-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-(4-phenoxyphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C(C=C1)=CC=C1OC1=CC=CC=C1 UBTNNQYFMVAWSA-UHFFFAOYSA-N 0.000 claims 1
- DIPUIJQPRWPKHP-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[1-(3-fluorophenyl)pyrazol-4-yl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC(N2N=CC(=C2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 DIPUIJQPRWPKHP-UHFFFAOYSA-N 0.000 claims 1
- YPKWQMAECYYHFL-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[2-fluoro-4-(4-propan-2-ylpiperazin-1-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C(F)=C1 YPKWQMAECYYHFL-UHFFFAOYSA-N 0.000 claims 1
- TYBIJLCPVSCJIJ-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[3-fluoro-4-(4-propan-2-ylpiperazin-1-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1CN(C(C)C)CCN1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1F TYBIJLCPVSCJIJ-UHFFFAOYSA-N 0.000 claims 1
- WUIJWRSPXISDAT-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(1,2-oxazol-4-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2=CON=C2)C=C1 WUIJWRSPXISDAT-UHFFFAOYSA-N 0.000 claims 1
- FAVUGUGYHZMFDP-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(1,2-oxazol-5-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2ON=CC=2)C=C1 FAVUGUGYHZMFDP-UHFFFAOYSA-N 0.000 claims 1
- QVZWVIYXVRVVFP-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(1-methylimidazol-2-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CN1C=CN=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 QVZWVIYXVRVVFP-UHFFFAOYSA-N 0.000 claims 1
- IXOMCKQEESRTTH-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(1-methylpyrazol-3-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CN1C=CC(C=2C=CC(=CC=2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=N1 IXOMCKQEESRTTH-UHFFFAOYSA-N 0.000 claims 1
- VDSIPWQVBDQOIF-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(1h-imidazol-2-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2NC=CN=2)C=C1 VDSIPWQVBDQOIF-UHFFFAOYSA-N 0.000 claims 1
- FEPKWKMQGCNDKH-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(2-chloropyrimidin-4-yl)phenyl]-3-methylsulfonyl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C=CC(=CC=3)C=3N=C(Cl)N=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(S(=O)(=O)C)=NN1C1=CC=CC=C1 FEPKWKMQGCNDKH-UHFFFAOYSA-N 0.000 claims 1
- WCBYBYFKBUHMRP-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(2-ethylimidazol-1-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CCC1=NC=CN1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 WCBYBYFKBUHMRP-UHFFFAOYSA-N 0.000 claims 1
- SJTMDYPARQJDJF-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(2-fluorophenyl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 SJTMDYPARQJDJF-UHFFFAOYSA-N 0.000 claims 1
- HRRDKUUOUZSFDI-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(2-methylimidazol-1-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=NC=CN1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 HRRDKUUOUZSFDI-UHFFFAOYSA-N 0.000 claims 1
- GCGNQBACGHELRT-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(2-methylphenyl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 GCGNQBACGHELRT-UHFFFAOYSA-N 0.000 claims 1
- ZYWUCANBKHJQRE-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(2-methylpyrazol-3-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CN1N=CC=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 ZYWUCANBKHJQRE-UHFFFAOYSA-N 0.000 claims 1
- VMDLPPCXABZQFN-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(2-methylpyrimidin-4-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=NC=CC(C=2C=CC(=CC=2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=N1 VMDLPPCXABZQFN-UHFFFAOYSA-N 0.000 claims 1
- DXDVUAFRRLFTQQ-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=NOC(C)=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 DXDVUAFRRLFTQQ-UHFFFAOYSA-N 0.000 claims 1
- UOXJPNOQIXYJJC-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(3,6-dimethylpyrazin-2-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CN=C(C)C(C=2C=CC(=CC=2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=N1 UOXJPNOQIXYJJC-UHFFFAOYSA-N 0.000 claims 1
- PLSMUDWFPDRGDV-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(3-fluorophenyl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC(C=2C=CC(=CC=2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 PLSMUDWFPDRGDV-UHFFFAOYSA-N 0.000 claims 1
- BJEHPWCUHIWNIP-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(4-fluorophenyl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 BJEHPWCUHIWNIP-UHFFFAOYSA-N 0.000 claims 1
- VMOLNJHNXPRHRC-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(4-fluorophenyl)piperazin-1-yl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1N1CCN(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 VMOLNJHNXPRHRC-UHFFFAOYSA-N 0.000 claims 1
- CTIWKIZBDJGRGP-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(4-methylimidazol-1-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=NC(C)=CN1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 CTIWKIZBDJGRGP-UHFFFAOYSA-N 0.000 claims 1
- KOYWLFQAJOMUTN-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(6-oxo-1h-pyridin-3-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2=CNC(=O)C=C2)C=C1 KOYWLFQAJOMUTN-UHFFFAOYSA-N 0.000 claims 1
- DJSQYPNNUTVVBL-UHFFFAOYSA-N 5-(4-chlorophenyl)-6-[4-(furan-3-yl)phenyl]-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C2=COC=C2)C=C1 DJSQYPNNUTVVBL-UHFFFAOYSA-N 0.000 claims 1
- RLLFOGZEYMBDAC-UHFFFAOYSA-N 5-(4-ethoxyphenyl)-1,6-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OCC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1 RLLFOGZEYMBDAC-UHFFFAOYSA-N 0.000 claims 1
- SXVDBDACKIJQFH-UHFFFAOYSA-N 5-(4-ethoxyphenyl)-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OCC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F SXVDBDACKIJQFH-UHFFFAOYSA-N 0.000 claims 1
- OBKCCUHDEJMTCI-UHFFFAOYSA-N 5-(4-ethoxyphenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OCC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C)C=C1 OBKCCUHDEJMTCI-UHFFFAOYSA-N 0.000 claims 1
- HQBCTHNFYGFTAV-UHFFFAOYSA-N 5-(4-fluorophenyl)-6-(2-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1C(N(C1=O)C=2C=CC(F)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 HQBCTHNFYGFTAV-UHFFFAOYSA-N 0.000 claims 1
- ALCGTUDMLRZXKN-UHFFFAOYSA-N 5-(4-fluorophenyl)-6-(3-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(F)=CC=2)=C1 ALCGTUDMLRZXKN-UHFFFAOYSA-N 0.000 claims 1
- FBCKUZYUFVWIBZ-UHFFFAOYSA-N 5-(4-fluorophenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(F)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 FBCKUZYUFVWIBZ-UHFFFAOYSA-N 0.000 claims 1
- ZSQUVPGLHAWOPI-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1,6-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1 ZSQUVPGLHAWOPI-UHFFFAOYSA-N 0.000 claims 1
- XGJYMGFLZJCJHO-UHFFFAOYSA-N 5-(4-methoxyphenyl)-6-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C)C=C1 XGJYMGFLZJCJHO-UHFFFAOYSA-N 0.000 claims 1
- WGPDUTXOBVXSRI-UHFFFAOYSA-N 5-(4-methylphenyl)-1,6-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1 WGPDUTXOBVXSRI-UHFFFAOYSA-N 0.000 claims 1
- KGOZTIXGPYWKJT-UHFFFAOYSA-N 5-(4-tert-butylphenyl)-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)(C)C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F KGOZTIXGPYWKJT-UHFFFAOYSA-N 0.000 claims 1
- MNDHYKAEBQEDNV-UHFFFAOYSA-N 5-benzyl-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)CC=2C=CC=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 MNDHYKAEBQEDNV-UHFFFAOYSA-N 0.000 claims 1
- IJIMFLXQXAUTDI-UHFFFAOYSA-N 5-cyclohexyl-6-(2-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C2CCCCC2)=NC2=C1C=NN2C1=CC=CC=C1 IJIMFLXQXAUTDI-UHFFFAOYSA-N 0.000 claims 1
- JHRIMKYMRQPWJX-UHFFFAOYSA-N 6-(2,4-dichlorophenyl)-5-(4-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1Cl JHRIMKYMRQPWJX-UHFFFAOYSA-N 0.000 claims 1
- YTKYNXCSIAETLJ-UHFFFAOYSA-N 6-(2-bromophenyl)-5-(4-bromophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Br)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1Br YTKYNXCSIAETLJ-UHFFFAOYSA-N 0.000 claims 1
- TVBZGMHWJKMUJW-UHFFFAOYSA-N 6-(2-chloro-4-morpholin-4-ylphenyl)-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(N2CCOCC2)C=C1Cl TVBZGMHWJKMUJW-UHFFFAOYSA-N 0.000 claims 1
- JEZSDRHESDMHBO-UHFFFAOYSA-N 6-(2-fluorophenyl)-1,5-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 JEZSDRHESDMHBO-UHFFFAOYSA-N 0.000 claims 1
- LWAQLQVROYFLHS-UHFFFAOYSA-N 6-(2-fluorophenyl)-1-phenyl-5-(4-phenylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 LWAQLQVROYFLHS-UHFFFAOYSA-N 0.000 claims 1
- KZONCDIPCRMYEE-UHFFFAOYSA-N 6-(2-fluorophenyl)-1-phenyl-5-(4-piperidin-1-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(=CC=2)N2CCCCC2)=NC2=C1C=NN2C1=CC=CC=C1 KZONCDIPCRMYEE-UHFFFAOYSA-N 0.000 claims 1
- IODYPLNWORELCU-UHFFFAOYSA-N 6-(2-fluorophenyl)-1-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F IODYPLNWORELCU-UHFFFAOYSA-N 0.000 claims 1
- YNGOZJVXBUBNBW-UHFFFAOYSA-N 6-(2-fluorophenyl)-1-phenyl-5-[4-(trifluoromethoxy)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(OC(F)(F)F)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 YNGOZJVXBUBNBW-UHFFFAOYSA-N 0.000 claims 1
- LTFVTABCNKTQEV-UHFFFAOYSA-N 6-(2-fluorophenyl)-1-phenyl-5-[4-(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=CC(=CC=2)C(F)(F)F)=NC2=C1C=NN2C1=CC=CC=C1 LTFVTABCNKTQEV-UHFFFAOYSA-N 0.000 claims 1
- RSPGDBGQPHGGOB-UHFFFAOYSA-N 6-(2-fluorophenyl)-1-phenyl-5-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC=CC=C1C(N(C1=O)C=2C=NC=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 RSPGDBGQPHGGOB-UHFFFAOYSA-N 0.000 claims 1
- JGNDNQVVNPAJMT-UHFFFAOYSA-N 6-(2-fluorophenyl)-5-(3-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(N2C(C=3C=NN(C=3N=C2C=2C(=CC=CC=2)F)C=2C=CC=CC=2)=O)=C1 JGNDNQVVNPAJMT-UHFFFAOYSA-N 0.000 claims 1
- ISKBCNMOTUDCIK-UHFFFAOYSA-N 6-(2-fluorophenyl)-5-(4-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F ISKBCNMOTUDCIK-UHFFFAOYSA-N 0.000 claims 1
- XRARRQSWWSOIRH-UHFFFAOYSA-N 6-(2-fluorophenyl)-5-(4-methoxyphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F XRARRQSWWSOIRH-UHFFFAOYSA-N 0.000 claims 1
- VOFVABHNXPTPSK-UHFFFAOYSA-N 6-(2-fluorophenyl)-5-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F VOFVABHNXPTPSK-UHFFFAOYSA-N 0.000 claims 1
- RXSSOCHQENKJPZ-UHFFFAOYSA-N 6-(2-fluorophenyl)-5-(4-methylsulfanylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(SC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F RXSSOCHQENKJPZ-UHFFFAOYSA-N 0.000 claims 1
- UVALKLHAOVESBN-UHFFFAOYSA-N 6-(3-methylphenyl)-1,5-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 UVALKLHAOVESBN-UHFFFAOYSA-N 0.000 claims 1
- SIOYQFGOQWFIAP-UHFFFAOYSA-N 6-(3-methylphenyl)-1-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC(C)=C1 SIOYQFGOQWFIAP-UHFFFAOYSA-N 0.000 claims 1
- DVUGYDCGGNOGIV-UHFFFAOYSA-N 6-(3-methylphenyl)-5-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC(C)=C1 DVUGYDCGGNOGIV-UHFFFAOYSA-N 0.000 claims 1
- CNBXMJSADODHEG-UHFFFAOYSA-N 6-(4-acetylphenyl)-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(=O)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 CNBXMJSADODHEG-UHFFFAOYSA-N 0.000 claims 1
- HCTLUSPPKSGJDR-UHFFFAOYSA-N 6-(4-bromo-2-chlorophenyl)-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1Cl HCTLUSPPKSGJDR-UHFFFAOYSA-N 0.000 claims 1
- WIRXLXSPIKMAHZ-UHFFFAOYSA-N 6-(4-bromo-2-fluorophenyl)-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(Br)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 WIRXLXSPIKMAHZ-UHFFFAOYSA-N 0.000 claims 1
- OEEJLILFNQTPJG-UHFFFAOYSA-N 6-(4-bromophenyl)-1-methyl-5-(4-methylphenyl)-3-phenylpyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N(C)N=C2C1=CC=CC=C1 OEEJLILFNQTPJG-UHFFFAOYSA-N 0.000 claims 1
- MYYLELYEUPMFPZ-UHFFFAOYSA-N 6-(4-bromophenyl)-1-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 MYYLELYEUPMFPZ-UHFFFAOYSA-N 0.000 claims 1
- VRPOMJYPGABUIY-UHFFFAOYSA-N 6-(4-bromophenyl)-2-methyl-5-(4-methylphenyl)-3-phenylpyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(C)=CC=C1C(N(C(=O)C1=NN2C)C=3C=CC(Br)=CC=3)=NC1=C2C1=CC=CC=C1 VRPOMJYPGABUIY-UHFFFAOYSA-N 0.000 claims 1
- ICPPYPLLKATGNJ-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(2,4-dimethylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC(C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 ICPPYPLLKATGNJ-UHFFFAOYSA-N 0.000 claims 1
- MXZAXCQRIHTBRX-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(2-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 MXZAXCQRIHTBRX-UHFFFAOYSA-N 0.000 claims 1
- KHTGFAORQYAINE-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(3-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound ClC1=CC=CC(N2C(C=3C=NN(C=3N=C2C=2C=CC(Br)=CC=2)C=2C=CC=CC=2)=O)=C1 KHTGFAORQYAINE-UHFFFAOYSA-N 0.000 claims 1
- GZLNDAPAIUIDQU-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(4-chlorophenyl)-3-(morpholine-4-carbonyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(C(C(=O)N2CCOCC2)=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 GZLNDAPAIUIDQU-UHFFFAOYSA-N 0.000 claims 1
- COTQVJQUIDYXSZ-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(4-chlorophenyl)-4-oxo-1-phenylpyrazolo[3,4-d]pyrimidine-3-carboxylic acid Chemical compound C1=2N=C(C=3C=CC(Br)=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(C(=O)O)=NN1C1=CC=CC=C1 COTQVJQUIDYXSZ-UHFFFAOYSA-N 0.000 claims 1
- WPQHRZBAWPIZPT-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(4-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 WPQHRZBAWPIZPT-UHFFFAOYSA-N 0.000 claims 1
- MMEHYYYPJXTOED-UHFFFAOYSA-N 6-(4-bromophenyl)-5-(4-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 MMEHYYYPJXTOED-UHFFFAOYSA-N 0.000 claims 1
- IXENPZAYCRHGQE-UHFFFAOYSA-N 6-(4-chlorophenyl)-1,5-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 IXENPZAYCRHGQE-UHFFFAOYSA-N 0.000 claims 1
- FSMFDXOFFGVLLA-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-methyl-3-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N(C)N=C2C1=CC=CC=C1 FSMFDXOFFGVLLA-UHFFFAOYSA-N 0.000 claims 1
- WKTLAPUKGWSFPN-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-methyl-3-phenyl-5-(4-pyridin-2-ylphenyl)pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=2N=C(C=3C=CC(=CC=3)C=3N=CC=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2N(C)N=C1C1=CC=CC=C1 WKTLAPUKGWSFPN-UHFFFAOYSA-N 0.000 claims 1
- SAGLDHMSYAHXKS-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-methylsulfonyl-3-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1N(S(C)(=O)=O)N=C2C1=CC=CC=C1 SAGLDHMSYAHXKS-UHFFFAOYSA-N 0.000 claims 1
- DOQGYGTUQNIPES-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-methyl-3-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C(=O)C1=NN2C)C=3C=CC(Cl)=CC=3)=NC1=C2C1=CC=CC=C1 DOQGYGTUQNIPES-UHFFFAOYSA-N 0.000 claims 1
- PSKSEVOQEBMJRH-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-methyl-3-phenyl-5-(4-pyridin-2-ylphenyl)pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C=1C=CC=CC=1C=1N(C)N=C(C(N2C=3C=CC(Cl)=CC=3)=O)C=1N=C2C(C=C1)=CC=C1C1=CC=CC=N1 PSKSEVOQEBMJRH-UHFFFAOYSA-N 0.000 claims 1
- ONDQRBXTUCVCJX-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-phenyl-5-(4-phenylphenyl)-1h-pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(NN=C2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 ONDQRBXTUCVCJX-UHFFFAOYSA-N 0.000 claims 1
- JSQOQIPCZONMJZ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-phenyl-5-(4-phenylphenyl)-[1,2]oxazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C2=NOC(C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 JSQOQIPCZONMJZ-UHFFFAOYSA-N 0.000 claims 1
- KOWUDTJUCMGPLQ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-phenyl-5-(4-propan-2-ylphenyl)-1h-pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1NN=C2C1=CC=CC=C1 KOWUDTJUCMGPLQ-UHFFFAOYSA-N 0.000 claims 1
- IWMQIKCUZYWWBG-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-phenyl-5-(4-propan-2-ylphenyl)-[1,2]oxazolo[4,3-d]pyrimidin-7-one Chemical compound C1=CC(C(C)C)=CC=C1C1=NC2=C(C=3C=CC=CC=3)ON=C2C(=O)N1C1=CC=C(Cl)C=C1 IWMQIKCUZYWWBG-UHFFFAOYSA-N 0.000 claims 1
- GTLQTIFTEXVLJD-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-phenyl-5-(4-propan-2-ylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-one Chemical compound C1=CC(C(C)C)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1ON=C2C1=CC=CC=C1 GTLQTIFTEXVLJD-UHFFFAOYSA-N 0.000 claims 1
- MOJVEXVNNANYJN-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C(=CC(Cl)=CC=2)Cl)=NC2=C1C=NN2C1=CC=CC=C1 MOJVEXVNNANYJN-UHFFFAOYSA-N 0.000 claims 1
- QVLRHMCAKVWHPC-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-3-phenylimidazo[4,5-b]pyridin-7-amine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C1=NC=2N(C=3C=CC=CC=3)C=NC=2C(N)=C1C1=CC=C(Cl)C=C1 QVLRHMCAKVWHPC-UHFFFAOYSA-N 0.000 claims 1
- MCXPYUXXXQJSHG-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(2,4-difluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound FC1=CC(F)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1 MCXPYUXXXQJSHG-UHFFFAOYSA-N 0.000 claims 1
- NVLXAGRSNYTNGV-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(2-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1 NVLXAGRSNYTNGV-UHFFFAOYSA-N 0.000 claims 1
- FCEIPDQFWTUOGR-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,5-dimethylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC(C)=CC(N2C(C=3C=NN(C=3N=C2C=2C=CC(Cl)=CC=2)C=2C=CC=CC=2)=O)=C1 FCEIPDQFWTUOGR-UHFFFAOYSA-N 0.000 claims 1
- BYDDPXHDRAOTMO-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3-methylphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound CC1=CC=CC(N2C(C=3C=NN(C=3N=C2C=2C=CC(Cl)=CC=2)C=2C=CC=CC=2)=O)=C1 BYDDPXHDRAOTMO-UHFFFAOYSA-N 0.000 claims 1
- XCDRNJXUUVWVMT-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(4-ethoxyphenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(OCC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1 XCDRNJXUUVWVMT-UHFFFAOYSA-N 0.000 claims 1
- FCYUOLKDUVVDJS-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(4-fluorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1 FCYUOLKDUVVDJS-UHFFFAOYSA-N 0.000 claims 1
- POYSPKBDRLZYEA-UHFFFAOYSA-N 6-(4-methylphenyl)-1,5-diphenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 POYSPKBDRLZYEA-UHFFFAOYSA-N 0.000 claims 1
- ZJMFIEXPQMBOLU-UHFFFAOYSA-N 6-(4-methylphenyl)-1-phenyl-5-(4-propan-2-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C(C)C)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C)C=C1 ZJMFIEXPQMBOLU-UHFFFAOYSA-N 0.000 claims 1
- VVSOPFHEBCYHKN-UHFFFAOYSA-N 6-[2-chloro-4-(4-methylpiperazin-1-yl)phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1CN(C)CCN1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C(Cl)=C1 VVSOPFHEBCYHKN-UHFFFAOYSA-N 0.000 claims 1
- SXNAFSAXVGSMRS-UHFFFAOYSA-N 6-[4-(2-aminopyrimidin-4-yl)phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound NC1=NC=CC(C=2C=CC(=CC=2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=N1 SXNAFSAXVGSMRS-UHFFFAOYSA-N 0.000 claims 1
- ZIUWTSBERAPYFU-UHFFFAOYSA-N 6-[4-(2-aminopyrimidin-4-yl)phenyl]-5-(4-chlorophenyl)-3-methylsulfanyl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C=CC(=CC=3)C=3N=C(N)N=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(SC)=NN1C1=CC=CC=C1 ZIUWTSBERAPYFU-UHFFFAOYSA-N 0.000 claims 1
- NALVOHWSZGQGAM-UHFFFAOYSA-N 6-[4-(2-aminopyrimidin-4-yl)phenyl]-5-(4-chlorophenyl)-3-methylsulfonyl-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=2N=C(C=3C=CC(=CC=3)C=3N=C(N)N=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(S(=O)(=O)C)=NN1C1=CC=CC=C1 NALVOHWSZGQGAM-UHFFFAOYSA-N 0.000 claims 1
- MQPMOVJMBCYFOH-UHFFFAOYSA-N 6-[4-(2-butoxyethenyl)phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(C=COCCCC)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 MQPMOVJMBCYFOH-UHFFFAOYSA-N 0.000 claims 1
- BNDXMOGJCSPPRR-UHFFFAOYSA-N 6-[4-(2-butoxyethyl)phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=CC(CCOCCCC)=CC=C1C(N(C1=O)C=2C=CC(Cl)=CC=2)=NC2=C1C=NN2C1=CC=CC=C1 BNDXMOGJCSPPRR-UHFFFAOYSA-N 0.000 claims 1
- MUCGSWNNGCNWKI-UHFFFAOYSA-N 6-[4-(4-aminopyridin-2-yl)phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound NC1=CC=NC(C=2C=CC(=CC=2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 MUCGSWNNGCNWKI-UHFFFAOYSA-N 0.000 claims 1
- JJTGAEUVVBDBNE-UHFFFAOYSA-N 6-[4-(6-aminopyrazin-2-yl)phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound NC1=CN=CC(C=2C=CC(=CC=2)C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=N1 JJTGAEUVVBDBNE-UHFFFAOYSA-N 0.000 claims 1
- QCZZLDSJIBOZKL-UHFFFAOYSA-N 6-[4-(6-aminopyridin-3-yl)phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound C1=NC(N)=CC=C1C1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 QCZZLDSJIBOZKL-UHFFFAOYSA-N 0.000 claims 1
- TYTOPSLDIBYYMY-UHFFFAOYSA-N 6-[4-[(2-aminocyclohexyl)amino]phenyl]-5-(4-chlorophenyl)-1-phenylpyrazolo[3,4-d]pyrimidin-4-one Chemical compound NC1CCCCC1NC1=CC=C(C=2N(C(=O)C=3C=NN(C=3N=2)C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)C=C1 TYTOPSLDIBYYMY-UHFFFAOYSA-N 0.000 claims 1
- GWRQXCHBZSXNRU-UHFFFAOYSA-N 7-(2-chlorophenyl)-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(C=2C(=CC=CC=2)Cl)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl GWRQXCHBZSXNRU-UHFFFAOYSA-N 0.000 claims 1
- MLONZKRFIOFHKG-UHFFFAOYSA-N 7-(5-chloro-2-methylphenyl)-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)purin-6-one Chemical compound CC1=CC=C(Cl)C=C1N1C(C(=O)N(C=2C=CC(Cl)=CC=2)C(C=2C(=CC(Cl)=CC=2)Cl)=N2)=C2N=C1 MLONZKRFIOFHKG-UHFFFAOYSA-N 0.000 claims 1
- YDVCQWHAUNKTNB-UHFFFAOYSA-N 7-benzyl-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(CC=2C=CC=CC=2)C=N2)=C2N=C1C1=CC=C(Cl)C=C1Cl YDVCQWHAUNKTNB-UHFFFAOYSA-N 0.000 claims 1
- QMCBRJDMUXDVEB-UHFFFAOYSA-N 7-benzyl-1-(4-chlorophenyl)-2-(4-phenylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N(CC=2C=CC=CC=2)C=N2)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 QMCBRJDMUXDVEB-UHFFFAOYSA-N 0.000 claims 1
- YWCJZLPNUMVQAN-UHFFFAOYSA-N 7-benzyl-2-(4-chlorophenyl)-1-(4-phenylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1C(N(C1=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)=NC2=C1N(CC=1C=CC=CC=1)C=N2 YWCJZLPNUMVQAN-UHFFFAOYSA-N 0.000 claims 1
- HCPZKZUKGNZREZ-UHFFFAOYSA-N 8-(bromomethyl)-1-(4-chlorophenyl)-9-phenyl-2-(4-phenylphenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=C(CBr)N2C=3C=CC=CC=3)=C2N=C1C1=CC=C(C=2C=CC=CC=2)C=C1 HCPZKZUKGNZREZ-UHFFFAOYSA-N 0.000 claims 1
- VJPMWWNCNBLURA-UHFFFAOYSA-N 8-bromo-1-(4-bromophenyl)-2-(4-methylphenyl)-9-phenylpurin-6-one Chemical compound C1=CC(C)=CC=C1C(N(C1=O)C=2C=CC(Br)=CC=2)=NC2=C1N=C(Br)N2C1=CC=CC=C1 VJPMWWNCNBLURA-UHFFFAOYSA-N 0.000 claims 1
- YLTJQDQJAGVNNO-UHFFFAOYSA-N 8-bromo-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=C(Br)N2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1Cl YLTJQDQJAGVNNO-UHFFFAOYSA-N 0.000 claims 1
- JEKFZGFWTFBSGB-UHFFFAOYSA-N 8-bromo-2-(4-bromophenyl)-1-(4-chlorophenyl)-9-phenylpurin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=C(Br)N2C=3C=CC=CC=3)=C2N=C1C1=CC=C(Br)C=C1 JEKFZGFWTFBSGB-UHFFFAOYSA-N 0.000 claims 1
- BPSZBCUVEKIWBZ-UHFFFAOYSA-N 9-(5-chloro-2-methylphenyl)-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)purin-6-one Chemical compound CC1=CC=C(Cl)C=C1N1C(N=C(C=2C(=CC(Cl)=CC=2)Cl)N(C=2C=CC(Cl)=CC=2)C2=O)=C2N=C1 BPSZBCUVEKIWBZ-UHFFFAOYSA-N 0.000 claims 1
- GREXLJIURDIPJP-UHFFFAOYSA-N 9-benzyl-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)purin-6-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)C(N=CN2CC=3C=CC=CC=3)=C2N=C1C1=CC=C(Cl)C=C1Cl GREXLJIURDIPJP-UHFFFAOYSA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000000044 Amnesia Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- WMWDBDYSKSIQBQ-UHFFFAOYSA-N BrC1=CC=C(C=C1)C=1N(C(C2=C(N1)N(N=C2C(=O)O)C2=CC=CC=C2)=O)C2=CC=C(C=C2)Cl.C(C)(C)OC(C)C Chemical compound BrC1=CC=C(C=C1)C=1N(C(C2=C(N1)N(N=C2C(=O)O)C2=CC=CC=C2)=O)C2=CC=C(C=C2)Cl.C(C)(C)OC(C)C WMWDBDYSKSIQBQ-UHFFFAOYSA-N 0.000 claims 1
- 208000032841 Bulimia Diseases 0.000 claims 1
- NCIVDFWIZQJWIN-UHFFFAOYSA-N CN(CC1)CCN1N(C=NC1=C2N=CN1C1=CC=CC=C1)C2=O Chemical compound CN(CC1)CCN1N(C=NC1=C2N=CN1C1=CC=CC=C1)C2=O NCIVDFWIZQJWIN-UHFFFAOYSA-N 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 claims 1
- 208000006029 Cardiomegaly Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010008190 Cerebrovascular accident Diseases 0.000 claims 1
- KDDZPNXTAYHVLF-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C(=NN2C2=CC=CC=C2)S(=O)(=O)C)C2=CC=C(C=C2)C2=CCN(C=C2)O Chemical compound ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C(=NN2C2=CC=CC=C2)S(=O)(=O)C)C2=CC=C(C=C2)C2=CCN(C=C2)O KDDZPNXTAYHVLF-UHFFFAOYSA-N 0.000 claims 1
- AUFJHKIJBSBIRQ-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2=C(CN(C=C2)O)C Chemical compound ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2=C(CN(C=C2)O)C AUFJHKIJBSBIRQ-UHFFFAOYSA-N 0.000 claims 1
- RVWAOGLBNXBMKQ-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2=CC(N(C=C2)O)C Chemical compound ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2=CC(N(C=C2)O)C RVWAOGLBNXBMKQ-UHFFFAOYSA-N 0.000 claims 1
- WAAQGUTVRURSGQ-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2=CCN(C=C2)O Chemical compound ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2=CCN(C=C2)O WAAQGUTVRURSGQ-UHFFFAOYSA-N 0.000 claims 1
- SHWTUDKUPBMIDQ-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2N(C=CC=C2)O Chemical compound ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C2N(C=CC=C2)O SHWTUDKUPBMIDQ-UHFFFAOYSA-N 0.000 claims 1
- PKXXSYHARQEYAY-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C=2CN(C=CC2)O Chemical compound ClC1=CC=C(C=C1)N1C(=NC2=C(C1=O)C=NN2C2=CC=CC=C2)C2=CC=C(C=C2)C=2CN(C=CC2)O PKXXSYHARQEYAY-UHFFFAOYSA-N 0.000 claims 1
- KJJLUPYSFWUOEX-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC=2N(C=NC2C1=O)C1=CC=CC=C1)C1=CC=C(C=C1)C1=CCN(C=C1)O Chemical compound ClC1=CC=C(C=C1)N1C(=NC=2N(C=NC2C1=O)C1=CC=CC=C1)C1=CC=C(C=C1)C1=CCN(C=C1)O KJJLUPYSFWUOEX-UHFFFAOYSA-N 0.000 claims 1
- RYEILHNLWFDVQK-UHFFFAOYSA-N ClC1=CC=C(C=C1)N1C(=NC=2N=CN(C2C1=O)C=1N(C2=CC=CC=C2C1)C(=O)O)C1=C(C=C(C=C1)Cl)Cl.C(C)(C)(C)OC(C)(C)C Chemical compound ClC1=CC=C(C=C1)N1C(=NC=2N=CN(C2C1=O)C=1N(C2=CC=CC=C2C1)C(=O)O)C1=C(C=C(C=C1)Cl)Cl.C(C)(C)(C)OC(C)(C)C RYEILHNLWFDVQK-UHFFFAOYSA-N 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 206010014612 Encephalitis viral Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 206010019196 Head injury Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 206010026749 Mania Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- FTEQEIYEPVRMOR-UHFFFAOYSA-N O=C1NC=NC2=C1C(C(C=C1)=CC(F)=C1N1CCOCC1)=NN2C1=CC=CC=C1 Chemical compound O=C1NC=NC2=C1C(C(C=C1)=CC(F)=C1N1CCOCC1)=NN2C1=CC=CC=C1 FTEQEIYEPVRMOR-UHFFFAOYSA-N 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 201000001883 cholelithiasis Diseases 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 230000007547 defect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000002474 dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- DRAGIKIPAJKHMR-UHFFFAOYSA-N ethyl 6-(4-bromophenyl)-5-(4-chlorophenyl)-4-oxo-1-phenylpyrazolo[3,4-d]pyrimidine-3-carboxylate Chemical compound C1=2N=C(C=3C=CC(Br)=CC=3)N(C=3C=CC(Cl)=CC=3)C(=O)C=2C(C(=O)OCC)=NN1C1=CC=CC=C1 DRAGIKIPAJKHMR-UHFFFAOYSA-N 0.000 claims 1
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000037906 ischaemic injury Diseases 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 230000005980 lung dysfunction Effects 0.000 claims 1
- 230000004199 lung function Effects 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- IOWAOXUHGGOVGL-UHFFFAOYSA-N methyl 4-[6-(2-fluorophenyl)-4-oxo-1-phenylpyrazolo[3,4-d]pyrimidin-5-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1N1C(=O)C(C=NN2C=3C=CC=CC=3)=C2N=C1C1=CC=CC=C1F IOWAOXUHGGOVGL-UHFFFAOYSA-N 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- WPNZRJUVWBOMHS-UHFFFAOYSA-N n-[[1-(4-chlorophenyl)-6-oxo-9-phenyl-2-(4-phenylphenyl)purin-8-yl]methyl]methanesulfonamide Chemical compound C=1C=CC=CC=1N1C(CNS(=O)(=O)C)=NC(C(N2C=3C=CC(Cl)=CC=3)=O)=C1N=C2C(C=C1)=CC=C1C1=CC=CC=C1 WPNZRJUVWBOMHS-UHFFFAOYSA-N 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000001272 neurogenic effect Effects 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 208000020016 psychiatric disease Diseases 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000022925 sleep disturbance Diseases 0.000 claims 1
- 201000009032 substance abuse Diseases 0.000 claims 1
- 231100000736 substance abuse Toxicity 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
- 230000009529 traumatic brain injury Effects 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- 238000009423 ventilation Methods 0.000 claims 1
- 201000002498 viral encephalitis Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract 2
- IGHOYRJWTWYAGY-UHFFFAOYSA-N 1,3-oxazole pyrimidine 2H-triazole Chemical class N1=CN=CC=C1.N1N=NC=C1.O1C=NC=C1 IGHOYRJWTWYAGY-UHFFFAOYSA-N 0.000 abstract 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 0 CC(NC1=C)=Nc2c1[o]nc2* Chemical compound CC(NC1=C)=Nc2c1[o]nc2* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/22—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62250804P | 2004-10-26 | 2004-10-26 | |
US60/622,508 | 2004-10-26 | ||
US67267005P | 2005-04-18 | 2005-04-18 | |
US60/672,670 | 2005-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2007119449A RU2007119449A (ru) | 2008-12-10 |
RU2431635C2 true RU2431635C2 (ru) | 2011-10-20 |
Family
ID=36228382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007119449/04A RU2431635C2 (ru) | 2004-10-26 | 2005-10-26 | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 |
Country Status (20)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2725616C2 (ru) * | 2015-07-23 | 2020-07-03 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Соединения |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20050696B1 (en) | 2003-01-14 | 2008-10-31 | Arena Pharmaceuticals Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
NZ544200A (en) | 2003-07-14 | 2009-07-31 | Arena Pharm Inc | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
JP2007519754A (ja) * | 2004-01-30 | 2007-07-19 | スミスクライン ビーチャム コーポレーション | 化合物 |
AR051596A1 (es) * | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
GB0506147D0 (en) * | 2005-03-24 | 2005-05-04 | Merck Sharp & Dohme | Therapeutic agents |
AU2006244027A1 (en) * | 2005-05-11 | 2006-11-16 | Merck Sharp & Dohme Limited | 2,3-substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilloid-1 receptor (VR1) |
WO2007000655A2 (en) * | 2005-06-28 | 2007-01-04 | Orchid Research Laboratories Limited | Novel pyrazolopyrimidinone derivatives |
JP2009514954A (ja) | 2005-11-04 | 2009-04-09 | ハイドラ バイオサイエンシズ インコーポレイテッド | Trpv3機能を変調するための化合物 |
JP4738419B2 (ja) * | 2005-11-30 | 2011-08-03 | 富士フイルムRiファーマ株式会社 | アミロイドの凝集及び/又は沈着に起因する疾患の診断薬及び治療薬 |
CA2645967C (en) * | 2006-03-30 | 2011-05-24 | Irm Llc | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
MX2009001043A (es) | 2006-08-08 | 2009-02-06 | Sanofi Aventis | Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso. |
AU2007288203B2 (en) | 2006-08-23 | 2013-01-17 | Neurogen Corporation | 2-phenoxy pyrimidinone analogues |
WO2008134300A1 (en) * | 2007-04-26 | 2008-11-06 | Irm Llc | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
WO2008140750A1 (en) | 2007-05-10 | 2008-11-20 | Hydra Biosciences Inc. | Compounds for modulating trpv3 function |
ES2439255T3 (es) * | 2007-06-21 | 2014-01-22 | Cara Therapeutics, Inc. | Imidazoheterociclos sustituidos |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
MX2010003117A (es) | 2007-09-20 | 2010-04-01 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de gpr119. |
WO2009079593A1 (en) * | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
EP2303897A4 (en) * | 2008-06-05 | 2012-02-22 | Harvard College | HIGH VALENCIA PALLADIUM FLUORIDE COMPLEXES AND USES THEREOF |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
US8324385B2 (en) * | 2008-10-30 | 2012-12-04 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
JP2012509351A (ja) | 2008-11-20 | 2012-04-19 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 有機化合物のフッ素化 |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
WO2011014520A2 (en) | 2009-07-29 | 2011-02-03 | Irm Llc | Compounds and compositions as modulators of gpr119 activity |
BR112012003973A2 (pt) | 2009-08-26 | 2015-09-08 | Sanofi Sa | hidratos de fluoroglicosídeo heteroaromático cristalinos, produtos farmacêuticos compreendendo estes compostos e seu uso |
MX2012004078A (es) | 2009-10-09 | 2012-07-25 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de gpr119. |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8697739B2 (en) | 2010-07-29 | 2014-04-15 | Novartis Ag | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
KR101871011B1 (ko) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료 |
EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
KR101326557B1 (ko) * | 2011-03-31 | 2013-11-08 | 주식회사종근당 | 카나비노이드 수용체〔cbi〕길항제로서의 벤즈아미드 유도체 |
WO2012142162A2 (en) * | 2011-04-12 | 2012-10-18 | President And Fellows Of Harvard College | Fluorination of organic compounds |
TW201311689A (zh) | 2011-08-05 | 2013-03-16 | 必治妥美雅史谷比公司 | 作為因子xia抑制劑之新穎巨環化合物 |
US9067943B2 (en) * | 2011-11-25 | 2015-06-30 | Hoffmann-La Roche Inc. | [1,2,3]triazolo[4,5-D]pyrimidine derivatives |
WO2014052622A1 (en) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Nickel fluorinating complexes and uses thereof |
WO2014052619A1 (en) | 2012-09-27 | 2014-04-03 | Irm Llc | Piperidine derivatives and compositions as modulators of gpr119 activity |
MY176797A (en) * | 2013-03-07 | 2020-08-21 | Hoffmann La Roche | Novel pyrazol derivatives |
EP2978751B1 (en) | 2013-03-25 | 2018-12-05 | Bristol-Myers Squibb Company | Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors |
JP6513636B2 (ja) | 2013-05-02 | 2019-05-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Cb2受容体アゴニストとしてのプリン誘導体 |
EP2991988B1 (en) | 2013-05-02 | 2017-05-31 | F. Hoffmann-La Roche AG | Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists |
ES2883923T3 (es) | 2013-09-06 | 2021-12-09 | Hoffmann La Roche | Derivados de triazol[4,5-d]pirimidina como antagonistas del receptor CB2 |
US10759764B2 (en) | 2013-10-18 | 2020-09-01 | President And Fellows Of Harvard College | Fluorination of organic compounds |
AU2016205361C1 (en) | 2015-01-06 | 2021-04-08 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
WO2016168638A1 (en) | 2015-04-17 | 2016-10-20 | Abbvie Inc. | Indazolones as modulators of tnf signaling |
AR104291A1 (es) | 2015-04-17 | 2017-07-12 | Abbvie Inc | Moduladores tricíclicos de la señalización por tnf |
US20160304496A1 (en) | 2015-04-17 | 2016-10-20 | Abbvie Inc. | Indazolones as modulators of tnf signaling |
PT3310760T (pt) | 2015-06-22 | 2022-11-10 | Arena Pharm Inc | Sal cristalino de l-arginina de ácido (r)-2-(7-(4-ciclopentil-3-(trifluorometil)benziloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para utilização em distúrbios associados a recetores de s1p1 |
EP3471712B1 (en) * | 2016-06-20 | 2024-01-03 | The Regents of The University of Michigan | Small molecule inhibitors of aldh and uses thereof |
WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
US20180072741A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyrimidine compounds and uses thereof |
WO2018049214A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer |
EP4119558A1 (en) | 2016-09-09 | 2023-01-18 | Incyte Corporation | Pyrazolopyridine compounds and uses thereof |
CN106632069A (zh) * | 2016-11-18 | 2017-05-10 | 山东友帮生化科技有限公司 | 3‑氯‑6‑肼基哒嗪的合成方法 |
WO2018152220A1 (en) | 2017-02-15 | 2018-08-23 | Incyte Corporation | Pyrazolopyridine compounds and uses thereof |
MX2019009841A (es) | 2017-02-16 | 2020-01-30 | Arena Pharm Inc | Compuestos y metodos para el tratamiento de la colangitis biliar primaria. |
WO2019051199A1 (en) | 2017-09-08 | 2019-03-14 | Incyte Corporation | 6-CYANO-INDAZOLE COMPOUNDS AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) MODULATORS |
IL276779B2 (en) | 2018-02-20 | 2024-04-01 | Incyte Corp | Derivatives and related compounds of N-(phenyl)-2-(phenyl)pyrimidine-4-carboxamide as HPK1 inhibitors for cancer treatment |
WO2019164847A1 (en) | 2018-02-20 | 2019-08-29 | Incyte Corporation | Indazole compounds and uses thereof |
US10745388B2 (en) | 2018-02-20 | 2020-08-18 | Incyte Corporation | Indazole compounds and uses thereof |
US11299473B2 (en) | 2018-04-13 | 2022-04-12 | Incyte Corporation | Benzimidazole and indole compounds and uses thereof |
CN112601516A (zh) | 2018-06-06 | 2021-04-02 | 艾尼纳制药公司 | 治疗与s1p1受体相关的病况的方法 |
US10899755B2 (en) | 2018-08-08 | 2021-01-26 | Incyte Corporation | Benzothiazole compounds and uses thereof |
TW202028207A (zh) | 2018-09-25 | 2020-08-01 | 美商英塞特公司 | 吡唑并嘧啶化合物及其用途 |
AU2020326703A1 (en) | 2019-08-06 | 2022-02-17 | Incyte Corporation | Solid forms of an HPK1 inhibitor |
WO2021154966A1 (en) | 2020-01-29 | 2021-08-05 | Kamari Pharma Ltd. | Compounds and compositions for use in treating skin disorders |
KR102584607B1 (ko) * | 2023-01-19 | 2023-10-04 | 아주대학교산학협력단 | 1h-피라졸-3-아마이드계 화합물 유도체를 포함하는 염증성 피부질환 예방 또는 치료용 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002026718A2 (en) * | 2000-09-29 | 2002-04-04 | Millennium Pharmaceutical, Inc. | Bicyclic pyrimidin-4-one based inhibitors of factor xa |
RU2003102888A (ru) * | 2000-08-01 | 2004-08-27 | Оно Фармасьютикал Ко., Лтд | Производные 3,4-дигидроизохинолина и фармацевтический агент, включающий его в качестве активного ингредиента |
WO2004087053A2 (en) * | 2003-03-25 | 2004-10-14 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
WO2004094417A1 (en) * | 2003-04-23 | 2004-11-04 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2631139B2 (ja) | 1988-10-06 | 1997-07-16 | ライオン株式会社 | 1H−ピラゾロ〔3,4−b〕ピラジン誘導体 |
KR0151816B1 (ko) | 1994-02-08 | 1998-10-15 | 강박광 | 신규의 치환된 피리딜 이미다졸 유도체 및 그의 제조방법 |
RU2272030C2 (ru) * | 2000-08-01 | 2006-03-20 | Оно Фармасьютикал Ко., Лтд. | Производные 3,4-дигидроизохинолина и фармацевтический агент, включающий его в качестве активного ингредиента |
JP3675813B2 (ja) * | 2002-06-06 | 2005-07-27 | エーザイ株式会社 | 新規縮合イミダゾール誘導体 |
US7091216B2 (en) | 2002-08-02 | 2006-08-15 | Merck & Co., Inc. | Substituted furo[2,3-b]pyridine derivatives |
WO2004037176A2 (en) | 2002-10-21 | 2004-05-06 | Bristol-Myers Squibb Company | Quinazolinones and derivatives thereof as factor xa inhibitors |
US7129239B2 (en) * | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
WO2004096130A2 (en) | 2003-04-24 | 2004-11-11 | Merck & Co., Inc. | Inhibitors of akt activity |
CA2545725A1 (en) * | 2003-11-14 | 2005-06-02 | Merck Sharp & Dohme Limited | Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
AR051596A1 (es) * | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
-
2005
- 2005-10-24 AR ARP050104440A patent/AR051596A1/es not_active Application Discontinuation
- 2005-10-25 TW TW094137369A patent/TW200630096A/zh unknown
- 2005-10-25 PE PE2005001251A patent/PE20060599A1/es not_active Application Discontinuation
- 2005-10-26 RU RU2007119449/04A patent/RU2431635C2/ru not_active IP Right Cessation
- 2005-10-26 CA CA2581225A patent/CA2581225C/en not_active Expired - Fee Related
- 2005-10-26 JP JP2007539039A patent/JP2008518016A/ja not_active Withdrawn
- 2005-10-26 CN CN2005800368900A patent/CN101048408B/zh not_active Expired - Fee Related
- 2005-10-26 CA CA2730374A patent/CA2730374A1/en not_active Abandoned
- 2005-10-26 MX MX2007004936A patent/MX2007004936A/es not_active Application Discontinuation
- 2005-10-26 BR BRPI0517015-0A patent/BRPI0517015A/pt not_active IP Right Cessation
- 2005-10-26 AU AU2005299421A patent/AU2005299421B2/en not_active Ceased
- 2005-10-26 WO PCT/US2005/038361 patent/WO2006047516A2/en active Application Filing
- 2005-10-26 IN IN2514DEN2007 patent/IN2007DN02514A/en unknown
- 2005-10-26 CN CN2011101210450A patent/CN102241680A/zh active Pending
- 2005-10-26 US US11/718,016 patent/US8158634B2/en not_active Expired - Fee Related
- 2005-10-26 EP EP05813001A patent/EP1807429A4/en not_active Withdrawn
-
2007
- 2007-04-12 IL IL182527A patent/IL182527A0/en unknown
- 2007-04-18 MA MA29834A patent/MA28937B1/fr unknown
- 2007-04-25 TN TNP2007000161A patent/TNSN07161A1/fr unknown
- 2007-04-25 KR KR1020077009370A patent/KR100919524B1/ko not_active Expired - Fee Related
- 2007-04-26 EC EC2007007421A patent/ECSP077421A/es unknown
- 2007-05-07 NO NO20072352A patent/NO20072352L/no not_active Application Discontinuation
-
2009
- 2009-12-24 AU AU2009251216A patent/AU2009251216A1/en not_active Abandoned
-
2011
- 2011-06-22 JP JP2011138840A patent/JP2011190281A/ja active Pending
-
2012
- 2012-03-08 US US13/415,565 patent/US20120225869A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2003102888A (ru) * | 2000-08-01 | 2004-08-27 | Оно Фармасьютикал Ко., Лтд | Производные 3,4-дигидроизохинолина и фармацевтический агент, включающий его в качестве активного ингредиента |
WO2002026718A2 (en) * | 2000-09-29 | 2002-04-04 | Millennium Pharmaceutical, Inc. | Bicyclic pyrimidin-4-one based inhibitors of factor xa |
WO2004087053A2 (en) * | 2003-03-25 | 2004-10-14 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
WO2004094417A1 (en) * | 2003-04-23 | 2004-11-04 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
Non-Patent Citations (1)
Title |
---|
Nielsen Е.Flemming. Chemica Scripta, 1984, vol.24, pp.208-233. * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2725616C2 (ru) * | 2015-07-23 | 2020-07-03 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Соединения |
US10975081B2 (en) | 2015-07-23 | 2021-04-13 | Glaxosmithkline Intellectual Property Development Limited | Substituted fused pyrazole compounds and their use as LRRK2 inhibitors |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2431635C2 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
JP6432624B2 (ja) | 3環性ヘテロ環化合物及びjak阻害剤 | |
CN103096718B (zh) | 可溶性鸟苷酸环化酶活化剂 | |
RU2424242C2 (ru) | Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1 | |
AU2009322836B2 (en) | Soluble guanylate cyclase activators | |
AU2011234398B2 (en) | Novel NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | |
JP2019535664A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
MX2014008201A (es) | Pirimidinas y triazinas fusionadas sustituidas y su uso. | |
JP2012515205A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
NZ565334A (en) | Pyrimidine compounds as serotonin receptor modulators | |
JP2017518326A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
JP2015525236A (ja) | 置換モルホリンを含む新規な2,3−ジヒドロ−1H−イミダゾ{1,2−a}ピリミジン−5−オンおよびこの1,2,3,4−テトラヒドロピリミド{1,2−a}ピリミジン−6−オン誘導体、その調製およびその製薬学的使用 | |
JP2023549055A (ja) | 複素環式スピロ化合物及びその使用方法 | |
CN104350056A (zh) | 端锚聚合酶的吡咯并嘧啶酮和吡咯并吡啶酮抑制剂 | |
CN102482286A (zh) | 新型1,2,3,4-四氢嘧啶并{1,2-a}嘧啶-6-酮衍生物、其制备以及其医药用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20141027 |